Adult Medicine Ambulatory Care Cardiology Central Nervous System Clinical Administration Critical Care Drug Information

Education and Training Emergency Medicine Endocrine and Metabolism Geriatrics GI/Liver/Nutrition Hematology/Oncology Immunology/Transplantation

Infectious Diseases Nephrology Pain and Palliative Care Pediatrics Pharmaceutical Industry PK/PD/PG Women’s Health

The Adult Medicine PRN consists of practitioners, residents, and students who have an interest in shaping the practice of adult medicine in a variety of inpatient and outpatient settings. The PRN currently has around 1000 members with diverse research, practice, education, and training experiences. The following paragraphs highlight some of the Adult Medicine PRN’s activities and member accomplishments.

Looking toward the ACCP Annual Meeting next fall, the Adult Medicine PRN has been actively planning two focus sessions. Tentatively, the first session will focus on all things statin, and the second is a joint session with the GI/Liver/Nutrition PRN that will focus on updates in the management of hepatic disease.

The PRN has been busy developing PRN-specific awards and detailing the award process. Several award recipients were recognized at the PRN’s business meeting last fall. Details can be found below.

Promotions

Jessica Starr, Pharm.D., BCPS; associate clinical professor of pharmacy practice at Auburn University.

Awards

Last fall at the Adult Medicine PRN business meeting, several of our members were recognized with PRN-specific awards: Mentoring Award – Julie Murphy, Pharm.D., BCPS; Resident Research Award – Kyle Sobecki, Pharm.D.; Student Research Award – Dante Gravino; Practitioner Registration Award – Mate Soric.

Sharon See, Pharm.D., BCPS, was named to the Pharmacotherapy Specialty Council of the Board of Pharmacy Specialties.

Sharon See, Pharm.D., BCPS, was recently selected as a 2013 Vincentian Research Fellow for St. John’s University.

Sarah M. Gaffney, Pharm.D., BCPS, received the 2012 Virginia Society of Health-System Pharmacists (VSHP) Clinical Pharmacy Practice Achievement Award. This award is presented by VSHP to recognize one or more VSHP members who have made a recent contribution to the establishment and provision of a patient-oriented pharmacy service that produces visible outcomes.

Jonathan Edwards and Mickala M. Thompson recently won the Silver Award at the Alabama Performance Excellence Awards Conference in January for their team showcase submission titled, “Impact and Advances of an Antimicrobial Management Team over Six Years.” The team consists of 15 participants from several disciplines. The team pharmacists include Edward H. Eiland III, Pharm.D., MBA, FASHP, BCPS (AQ-ID); Jonathan D. Edwards, Pharm.D., BCPS; Mickala M. Thompson, Pharm.D., BCPS; Nicholas L. Massie, Pharm.D.; and Michael McDaniel, BSPharm, MBA, FASHP.

Grants

Nancy Toedter Williams, Pharm.D., FASHP, BCPS, BCNSP, Southwestern Oklahoma State University (SWOSU), in partnership with Walgreens, was the recipient of a Community Pharmacy Residency Expansion Project grant for $50,000.

Publications

• Soric MM, ed. Maximize Your Rotations: ASHP’s Student Guide to IPPEs, APPEs, and Beyond. Bethesda, MD: American Society of Health-System Pharmacists, 2013.
• Wallace JL, George CM, Tolley EA, Winton JC, Fasanella D, Finch CK, Self TH. Peak expiratory flow in bed? A comparison of 3 positions. Respir Care. 2012 Aug 16. [Epub ahead of print]
• Wallace JL, Reaves AB, Tolley EA, Oliphant CS, Hutchison L, Alabdan NA, Sands CW, Self TH. Comparison of initial warfarin response in obese patients versus non-obese patients. J Thromb Thrombolysis. 2012 Sep 27. [Epub ahead of print]
• Self TH, Wallace JL, Soberman JE. Cardioselective beta-blocker treatment of hypertension in patients with asthma: when do benefits outweigh risks? J Asthma 2012;49:947-51.
• See S, Ginzburg R. Gastroesophageal reflux disease. In: Richardson M, Chant C, Cheng JWM, Chessman KH, Hume AL, Hutchison LC, et al., eds. Pharmacotherapy Self-Assessment Program, 7th ed. Gastroenterology and Nutrition. Lenexa, KS: American College of Clinical Pharmacy, 2012:109-26.
• Sobieraj DM, White WB, Baker WL. Cardiovascular effects of pharmacologic therapies for smoking cessation. J Am Soc Hypertens 2013;7:61-7.
• Lee S, Coleman CI, Limone B, Kaur R, White CM, Kluger J, Sobieraj DM. Biologic and Nonbiologic Systemic Agents and Phototherapy for Treatment of Chronic Plaque Psoriasis [Internet]. Rockville, MD: Agency for Healthcare Research and Quality, 2012.
• Bhardwaj S, Coleman CI, Sobieraj DM. Efficacy of statins in combination with interferon therapy in multiple sclerosis: a meta-analysis. Am J Health Syst Pharm 2012;69:1494-9. 
• Sobieraj DM, White CM, Alikhanov S, Winkler S, Mediouni M, Kluger J, Coleman CI. The impact of antiplatelet and anticoagulant therapies on gastrointestinal symptoms in patients with atrial fibrillation: a systematic review. Ann Pharmacother 2012;46:1220-31.
• Coleman CI, Limone B, Sobieraj DM, Lee S, Roberts MS, Kaur R, Alam T. Dosing frequency and medication adherence in chronic disease. J Manage Care Pharm 2012;18:527-39.
• Sobieraj DM, Coleman CI, Tongbram V, Chen W, Colby J, Lee S, Kluger J, Makanji S, Ashaye A, White CM. Comparative effectiveness of low-molecular weight heparins versus other anticoagulants in major orthopedic surgery: a systematic review and meta-analysis. Pharmacotherapy 2012;32:799-808.
• Coleman CI, Phung OJ, Cappelleri JC, Baker WL, Kluger J, White CM, Sobieraj DM. Use of mixed treatment comparisons in systematic review [Internet]. Rockville, MD: Agency for Healthcare Research and Quality, 2012.
• Sobieraj DM, Lee S, Coleman CI, Tongbram V, Chen W, Colby J, Kluger J, Makanji S, Ashaye AO, White CM. Prolonged versus standard-duration venous thromboprophylaxis in major orthopedic surgery: a systematic review. Ann Intern Med 2012;156:720-7.
• Vande Griend JP, Anderson SL. Histamine₁ receptor antagonism for the treatment of insomnia. J Am Pharm Assoc 2012;52:e210-9.
• Toussaint KA, Watson K, Marrs JC, Sturpe DA, Anderson SL, Haines ST. Prevalence of and factors that influence board certification among pharmacy practice faculty at United States colleges and schools of pharmacy. Pharmacotherapy 2013;33:105-11.
• Dolder CR, Olin JL, Alston G. Prospective measurement of a problem-based learning course sequence. Am J Pharm Educ 2012;76:Article 179.
• Olin JL, Spooner LM, Klibanov OM. Elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate single tablet for HIV-1 infection treatment. Ann Pharmacother 2012;46:1671-7.
• Spooner LM, Olin JL. Tesamorelin: a growth hormone-releasing factor analogue for HIV-associated lipodystrophy. Ann Pharmacother 2012;46:240-7.
• Griffiths CL, Olin JL. Triple negative breast cancer: a brief review of its characteristics and treatment options. J Pharm Pract 2012;25:319-23. 
• Toussaint KA, Watson K, Marrs JC, Sturpe DA, Anderson SL, Haines ST. Prevalence of and factors that influence board certification among pharmacy practice faculty at United States colleges and schools of pharmacy. Pharmacotherapy 2013;33:105-11.
• Vande Griend JP, Anderson SL. Histamine₁ receptor antagonism for the treatment of insomnia. J Am Pharm Assoc 2012;52:e210-9.
• Woytowish MR, Maynor LM. Clinical relevance of linezolid-associated serotonin toxicity (March). Ann Pharmacother. 2013 Feb 19. www.theannals.com/content/early/2013/02/19/aph.1R386.abstract.html.
• Karaoui L, Chahine E, El-Lababidi R. Oritavancin: a novel lipoglycopeptide antibiotic. Am J Health Syst Pharm 2013;70:23-33.

New ACCP Fellows

Shareen El-Ibiary, Pharm.D., BCPS; Midwestern University College of Pharmacy-Glendale.

Brian A. Hemstreet, Pharm.D., BCPS; University of Colorado – Denver.

Julie A. Murphy, Pharm.D., BCPS; The University of Toledo.

Other Notable Achievements

Amy Skiff, Pharm.D., BCPS, received BCPS certification.

 

Promotions

• Kelly Rudd was promoted to the clinical pharmacology service coordinator at the Bassett Medical Center in Cooperstown, New York; she also serves as regional coordinator of anticoagulation services there.
• Eric Ip of Touro University California College of Pharmacy was promoted to associate professor.

Awards

• Krystal Edwards was awarded the Texas Tech University Health Sciences Center President’s Outstanding Clinician Award in fall 2012.
• Eric MacLaughlin was awarded the Texas Tech University Health Sciences Center President’s Excellence in Teaching Award in fall 2012.
• Eric Ip was named the 2012 Touro University California College of Pharmacy Professor of the Year.

Grants

• Thurston MM, Huang V, Ryan GJ, Huston SA, Bourg CA, Phillips BB, Haomiao J. Impact of Health Literacy on Aspects of Medication Nonadherence Reported by Underserved Patients with Type 2 Diabetes. 2012 ACCP Ambulatory Care PRN seed grant, $1547.60
• Dave Dixon (VCU) received a grant ($800) from the VCU Center for Teaching Excellence: Use of Video Recorded Clinic Visits to Improve Assessment of Pharmacy Student Clinical Interviewing Skills. He received a resource development award of $2000 from the Association of American Medical Colleges and Interprofessional Education Collaborative for developing an Interprofessional Team-Based Learning Module on Anticoagulation.
• Martin Bishop received one of the 2012–2013 ASHP R&E Foundation Resident Research Grants (up to $5000).
• Eric Ip as principal investigator was awarded a $3400+ intramural $3400+ grant for a project titled “Survey of Patient Acetaminophen Knowledge and the Impact of a Condensed Educational Consultation” by the Touro University California.
• Edith Nutescu, Pharm.D., FCCP, clinical professor at the University of Illinois College of Pharmacy, Department of Pharmacy Practice and Center for Pharmacoepidemiology and Pharmacoeconomic Research, was awarded a 4-year K23 grant from the National Institutes of Health/National Heart Lung and Blood Institute to study health disparities and factors influencing adoption and feasibility of anticoagulation self-monitoring in minority underserved patients. Other UIC investigators on the project were Marian Fitzgibbon, Ph.D.; Ben Gerber, M.D., MPH; Lisa Sharp, Ph.D.; Thomas Stamos, M.D.; and Michael Berbaum, Ph.D. Additional collaborators include David Meltzer, M.D., Ph.D., from the University of Chicago and Elaine Hylek, M.D., MPH, from Boston University.
• Melanie Claborn and colleagues received a $5000 grant from the National Association of Chain Drug Stores Foundation for the Million Hearts Initiative by University of Arkansas for Medical Sciences College of Pharmacy-Northwest – Scott Warmack, Melanie Claborn, Victoria Seaton, Eleanor Hughes, Leslie Hitt.

Publications

• Phillips BB, Thurston MM. Osteoporosis. In: Chisholm-Burns MA, Wells BG, Schwinghammer TL, Malone PM, Kolesar JM, DiPiro JT, eds. Pharmacotherapy Principles & Practice, 3rd ed. New York: McGraw-Hill, January 2013.
• Dixon DL, Lyles A, Sicat BL, Lee B, Rybarcyzyk B, Lord B. Interprofessional Team-Based Learning Module: Anticoagulation. MedEdPORTAL 2013. Available at www.mededportal.org/publication/9334. Accessed April 6, 2013.
• Siskey J, Lyles A, Dixon DL. Beta-blockers and hypertension: where are the data? Arch Intern Med 2012;172:1406-12. iForumRx.org. Available at http://iforumrx.com/index.php?q=node/136.
• Coles T, Dixon DL. Another bust for omega-3 fatty acids – it’s time to go fishing elsewhere. N Engl J Med 2012;367:309-18. iForumRx.org. Available at http://iforumrx.org/index.php?q=node/131.
• Essex MN, O’Connell M, Bhadra P. Response to nonsteroidal anti-inflammatory drugs in African Americans with osteoarthritis of the knee. J Int Med Res 2012;40:2251-66.
• White RR, Nickerson-Troy JA. Preventive medicine and wellness promotion. In: Dong B, Elliot D, eds. Ambulatory Care Self-Assessment Program, 2013 Book I. Pulmonary and Preventive Care. Lenexa, KS: American College of Clinical Pharmacy, 2013:119-33.
• Rudd KM, Phillips EL. New oral anticoagulants in the treatment of pulmonary embolism: efficacy, bleeding risk, and monitoring. Thrombosis. Accepted for publication January 31, 2013.
• Hiteshew KJ, Franz T, Lamberjack K, Chen AMH. Don’t leave without them: dispensing asthma medications to pediatric patients upon discharge is associated with decreased hospital readmissions. Innov Pharm 2012;3:Article 2.
• Bourg CA, Grigg E, May DW. Peptic ulcer disease. In: Chisholm MA, Schwinghammer TL, Wells BG, DiPiro JT, Kolesar JM, Malone PM, eds. Pharmacotherapy Principles & Practice, 3rd ed. New York: McGraw-Hill, 2013.
• Soric MM, ed. Maximize Your Rotations: ASHP’s Student Guide to IPPEs, APPEs, and Beyond. Bethesda, MD: American Society of Health-System Pharmacists, 2013.
• Yu J, Shah BM, Ip EJ, Chan J. A Markov model of the cost-effectiveness of pharmacist care for diabetes in prevention of cardiovascular diseases: evidence from Kaiser Permanente Northern California. J Manage Care Pharm 2013;19:102-14.
• Ip EJ, Bui QV, Barnett MJ, Kazani A, Wright R, Serino MJ, Perry PJ. The effect of trazodone on standardized field sobriety tests. Pharmacotherapy. 2013 Feb 28.
• Ip EJ, Lu DH, Barnett MJ, Tenerowicz MJ, Vo JC, Perry PJ. The psychological and physical impact of anabolic-androgenic steroid (AAS) dependence: a comparison of AAS-dependent users and AAS-non-dependent users. Pharmacotherapy 2012;32:910-9.
• Truong HB, Ip EJ. A review of erythropoietin abuse: an analysis of effectiveness and safety in exercise. J Sports Med Doping Stud 2012;2:106. 

Other Notable Achievements

• Christina Madison was named 2013 president of Nevada Public Health Association (she is one of only two pharmacists in the country to hold this type of position).
• Maria Thurston was awarded the 2012 Outstanding Young Health-System Pharmacist, Georgia Society of Health-System Pharmacists.
• Dave Dixon (VCU) passed the examination for certification as a Clinical Lipid Specialist (CLS) and was awarded Diplomate status with the Accreditation Council for Clinical Lipidology.
• Margaret Noyes Essex and colleagues presented abstracts at the American College of Gastroenterology (ACG) 77th Annual Scientific Meeting; October 19–24, 2012; Las Vegas, NV (Joshi A, Margolis M, Cappelleri J, Hsieh R, Noyes Essex M, Park P, Coyne K. Factors associated with gastroprotective agent use and adherence among adults with arthritis taking NSAIDs in the United States) and at the American College of Rheumatology (ACR); November 9–14, 2012; Washington, DC (Sands GS, Bhadra P, Noyes Essex M. The effect of age on the number of osteoarthritis flares with continuous versus intermittent celecoxib treatment).
• Mary Parker was installed as the North Carolina Association of Pharmacists president for 2013.
• Kelly Rudd was elected as president-elect of the NYS ACCP Chapter and appointed as an IPRO Anticoagulation Coalition Steering Committee member.
• Rachel Selinger attained her CDE and is now the sole CDE of any department at the UNC Chapel Hill’s Campus Health Services.
• Catherine Bourg and Beth Phillips of the University of Georgia COP delivered a presentation at this year’s ASHP Midyear Clinical Meeting, titled “Workshop: Evaluating Your Interviewing Skills,” as part of their student programming.
• Jennie Broders was accepted into the Society of Teachers of Family Medicine Emerging Leaders program.
• Bob Talbert was the speaker for the March Rho Chi banquet for the University of Kentucky.
• Edith Nutescu, Pharm.D., FCCP, clinical professor at the University of Illinois College of Pharmacy, Department of Pharmacy Practice, and Center for Pharmacoepidemiology and Pharmacoeconomic Research, was quoted in a Nature.com story about new blood thinners that are arriving on the market and how they compare in effectiveness with warfarin, a popular older anticoagulant antidote. 

 

The ACCP Cardiology PRN has recently been focused on our role delineation survey for the consideration of cardiology as a separate certification from the Board of Pharmacy Specialties. In addition, we have focused on developing our fundraising efforts to ensure that the withdrawal of industry support does not hinder our ability to fund seed grants, student/resident travel awards, or various other important projects for our PRN.

Promotions

Tina Denetclaw advanced to clinical professor, Department of Clinical Pharmacy, School of Pharmacy, University of California – San Francisco.

Craig R. Lee was promoted to associate professor of pharmacy (with tenure), Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina Eshelman School of Pharmacy.

Awards

Sarah Gaffney received the 2012 Virginia Society of Health-System Pharmacists Clinical Pharmacy Practice Achievement Award.

Grants

Johnson SG. Pharmacy Resident Practice-Based Research Grant for CYP2C19 Pilot Study. ASHP Research and Education Foundation. Role: Senior investigator.

Tisdale JE. Sensitivity to drug-induced QT-interval lengthening in patients with heart failure with preserved left ventricular ejection fraction. Center of Excellence in Cardiovascular Research (CECARE), Indiana Clinical Translational Sciences Institute (CTSI), Indiana University (IU) School of Medicine, and IU Health. $160,000. November 1, 2012 – October 31, 2014. Role: Principal investigator.

Publications

• O’Gara PT, Kushner FG, Ascheim DD, Casey DE, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz MH, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ,. Tamis-Holland JE, Tommaso CL, Tracy CM, Woo RY, Zhao DX. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013;61:e78-140.
• Adams AS, Uratsu C, Dyer W, Magid D, O’Conner P, Beck A, Butler MG, Ho M, Schmittdiel J. Antihypertensive adherence among a diverse cohort of newly treated patients. Arch Intern Med 2012;10:1-8.
• Byrd JB, Powers JD, Magid DJ, Tavel H, Schmittdiel J, O’Connor P, Margolis K, Beck A, Butler MG, Ho M. Detection and recognition of hypertension in anxious and depressed patients. J Hypertens 2012;30:2293-8.
• Chow SL. Heart failure with preserved ejection fraction. In: Murphy J, Lee M, eds. Pharmacotherapy Self-Assessment Program, 8th ed. Book 2. Cardiology and Endocrinology. Lenexa, KS: American College of Clinical Pharmacy, 2013:153-72.
• Wang JSC, Kovanecz I, Vernet D, Nolazco G, Kopchok GE, Chow SL, White RA, Gonzalez-Cadavid NF. Effects of sildenafil and/or muscle-derived stem cells on myocardial infarction. J Transl Med 2012;10:1-11.
• LaForest SK, Chow SL, DiDomenico R, Dracup K, Ensor C, Gattis-Stough W, Heywood JT, Lindenfeld J, Page RL, Patterson JH, Vardeny O, Massie BM. Clinical pharmacy services in heart failure: an opinion paper from the Heart Failure Society of America and American College of Clinical Pharmacy Cardiology Practice and Research Network. In press. Co-publication in Journal of Cardiac Failure and Pharmacotherapy, April 2013.
• Johnson SG. Clinical pharmacogenomics: potential impact on cardiovascular disease outcomes. In: Page RL, Murphy JM, et al., eds. Pharmacotherapy Self-Assessment Program, 8th ed. Lenexa, KS: American College of Clinical Pharmacy, 2013.
• Dobesh PP, Beavers CJ, Herring HR, Spinler SA, Stacey ZA, Trujillo TC. Key articles and guidelines in the management of acute coronary syndrome and in percutaneous coronary intervention: 2012 update. Pharmacotherapy 2012;32:e348-86.
• Stover R, Lane MA, Gokun Y, Elayi SC, Macaulay TE, Beavers CJ, Knight J. Sotalol versus amiodarone in atrial arrhythmias: impact of renal insufficiency and ejection fraction. ASHP Annual Midyear Meeting; 2012; Las Vegas, NV.
• Tisdale JE. Arrhythmias. In: Chisholm-Burns MA, Wells BG, Schwinghammer TL, Malone PM, Kolesar JM, DiPiro JT, eds. Pharmacotherapy Principles & Practice, 3rd ed. New York: McGraw-Hill, 2013:169-95.
• Mohamed AN, Abdelhady AM, Spencer D, Sowinski KM, Tisdale JE, Overholser BR. Pharmacokinetic modeling and simulation of procainamide and N-acetylprocainamide in a patient receiving CRRT: a novel approach to guide renal dose adjustments. Am J Kidney Dis 2013. In press.
• Hollands JM, Gowan M, Riney JN, Deal EN, Kates AM. Role of new drugs for management of atrial fibrillation. Ann Pharmacother 2012;46:1656-70.
• Lalama J. Arrhythmias. In: Attridge RL, Miller ML, Moote R, Ryan L, eds. Internal Medicine: A Guide to Clinical Therapeutics. New York: McGraw-Hill, 2013:25.
• Lalama J, Lewis PM, Gore J, Tran MT, Donovan J. How one academic medical center has managed potency changes with unfractionated heparin. J Thromb Thrombolysis. 2012. [Epub ahead of print]
• Young SK, Riding D, Antonio ME, Al-Mondhiry MA. Efficacy of a nurse-managed argatroban dose-adjustment protocol in a university teaching hospital. Hosp Pharm 2012;47:712-20.
• McConnell KJ, Shaw PB. Cardiovascular complications in patients with diabetes. In: Murphy J, Lee M, eds. Pharmacotherapy Self-Assessment Program, 2013 Book 1. Cardiology and Endocrinology. Lenexa, KS: American College of Clinical Pharmacy, 2013:25-48.
• McConnell KJ, Delate T, Newlon CL. Impact of continuing professional development versus traditional continuing pharmacy education on learning behaviors. J Am Pharm Assoc 2012;52:742-52.
• Sobieraj DM, White WB, Baker WL. Cardiovascular effects of pharmacologic therapies for smoking cessation. J Am Soc Hypertens 2013;7:61-7.
• Baker WL, Marrs JC, Davis LE, Nutescu EA, Rowe AS, Ryan M, Splinter MY, Vardeny O, Fagan SC. Key articles and guidelines in the primary prevention of ischemic stroke. Pharmacotherapy. 2013 Feb 11.
• Baker WL, Marrs JC, Davis LE, Nutescu EA, Rowe AS, Ryan M, Splinter MY, Vardeny O, Fagan SC. Key articles and guidelines in the acute management and secondary prevention of ischemic stroke. Pharmacotherapy. 2013 Feb 11.
• Denetclaw TH, Cefalu P, Manila LL, Panagotacos JJ. Needs analysis for educating community pharmacists to interface with prehospital stroke chain of survival. J Stroke Cerebrovasc Dis 2012. pii: S1052-3057(12)00382-5.
• Theken KN, Schuck RN, Edin ML, Tran B, Ellis K, Bass A, Lih FB, Tomer KB, Poloyac SM, Wu MC, Hinderliter AL, Zeldin DC, Stouffer GA, Lee CR. Evaluation of cytochrome P450-derived eicosanoids in humans with stable atherosclerotic cardiovascular disease. Atherosclerosis 2012;222:530-6.
• Marczak ED, Marzec J, Zeldin DC, Kleeberger SR, Brown NJ, Pretorius M, Lee CR. Polymorphisms in the transcription factor NRF2 and forearm vasodilator responses in humans. Pharmacogenet Genomics 2012;22:620-8.
• Crossman S, Stevens M, Ryan M, Mack D, Dixon D. Interprofessional global service learning through HOMBRE (Honduras Outreach Medical Brigade Relief Effort). Presented at: Jewell and Carol Emswiller Interprofessional Symposium; 2013; Richmond, VA.
• Dixon DL, Lyles A, Sicat BL, Lee B, Rybarcyzyk B, Lord B. Interprofessional Team-Based Learning Module: Anticoagulation. MedEdPORTAL 2013. Available at www.mededportal.org/publication/.
• Siskey J, Lyles A, Dixon DL. Beta-blockers and hypertension: where are the data? Arch Intern Med 2012;172:1406-12. iForumRx.org. Available at http://iforumrx.com/index.php?q=node/136. 

Other Notable Achievements

Sheryl L. Chow:  Elected as Fellow of the American Heart Association (FAHA).

Samuel G. Johnson:

• Appointed to the ACCP Task Force on Practice Innovation, 2012–2013.
• Appointed as Faculty Panel Chair (Cardiology Book) for the Ambulatory Care Self-Assessment Program (ACSAP) (Dong B, Elliott D, eds.).
• Installed as inaugural Institute of Medicine Anniversary Fellow in Pharmacy, 2012–2014.

Craig Beavers:  Beginning a 3-year council position on the Cardiovascular Team Council for the American College of Cardiology Foundation.

Barbara Wiggins:

• Asked to serve on the Editorial Board of Clinical Cardiovascular Drugs.
• Appointed to the Council on Clinical Practice of the American College of Cardiology. 

Mary Parker:  Installed in October as the 2013 president of the North Carolina Association of Pharmacists.

Augustus (Rob) Hough and David Parra:  Developed and released a tutorial and interactive smartphone (iPhone/iPad, Android) application on using plasma renin activity to guide antihypertensive therapy. The application software, which is available to the public free of charge, can be accessed at https://itunes.apple.com/us/app/pra-and-htn/id601765986?mt=8 for the iPhone/iPad.

Dave L. Dixon: 

• Passed the examination for certification as a Clinical Lipid Specialist (CLS), and he was awarded Diplomate status with the Accreditation Council for Clinical Lipidology.
• Received a resource development award of $2000 from the Association of American Medical Colleges and Interprofessional Education Collaborative for developing an Interprofessional Team-Based Learning Module on Anticoagulation.

 

Publications

• Chen JJ, Dashtipour K. Abo-, inco-, ona-, and rima-botulinum toxins in clinical therapy: a primer. Pharmacotherapy 2013;33:304-18.
• Leppik IE, Hovinga CA. Extended-release antiepileptic drugs: a comparison of pharmacokinetic parameters relative to original immediate-release formulations. Epilepsia 2013;54:28-35.
• Baker WL, Marrs JC, Davis LE, Nutescu EA, Rowe AS, Ryan M, Splinter MY, Vardeny O, Fagan SC. Key articles and guidelines in the primary prevention of ischemic stroke. Pharmacotherapy 2013. (doi: 10.1002/phar.1255)
• Baker WL, Marrs JC, Davis LE, Nutescu EA, Rowe AS, Ryan M, Splinter MY, Vardeny O, Fagan SC. Key articles and guidelines in the acute management and secondary prevention of ischemic stroke. Pharmacotherapy 2013. (doi: 10.1002/phar.1252)

 

The Clinical Administration PRN continues to grow (now at 387 members) and is actively pursuing a list of endeavors for 2013. The Programming/Focus Session Committee is working to address one of the main concerns voiced by members in our most recent survey. The program is titled “Advancing the Pharmacy Practice Model Through Effective Staff Development Strategies.”

The Research and Scholarship Committee is working on an application for a scholarship for students or residents to travel to the ACCP Annual Meeting and possibly to reimburse some BPS examinations. Students are requesting a more active role in the PRN. This year was no exception, with three students and one resident attending the PRN meeting. It is exciting to see recent graduates excited about leadership in the clinical administration arena. The PRN is excited to continue developing young leaders through involvement in activities of the PRN.

The PRN has renewed dialogue with the Leadership Academy and is actively engaged in seeking topics, editors, and names of potential speakers for the Academy Newsletter and Certificate Program.

Notable Achievements

John Noviasky, Pharm.D., BCPS, clinical coordinator at Upstate University Hospital at Community General. Since transitioning to this position, he has opened two pharmacy satellites, is cochair of the Pharmacy and Therapeutics Committee, and actively rounds with hospitalists. Dr. Noviasky also recently published an article titled “Effectiveness of Sodium Polystyrene Sulfonate in Decreasing Serum Potassium” in the International Journal of Nephrology and Renovascular Disease, vol 2012; Article ID 940320.

Kenneth Komorny, Pharm.D., BCPS; Mary Hailer, Pharm.D., BCPS; and Maria Giannakos, Pharm.D., MBA, BCPS, from Summa Health System all received their Lean Six Sigma Green Belt Certifications. Their project was related to pharmacy-managed warfarin consults and development of an Antimicrobial Stewardship Team.

Andrea Chbeir, Pharm.D., BCPS, clinical coordinator at Blessing Hospital, completed the Society of Infectious Diseases Pharmacists (SIDP) Antimicrobial Stewardship Certificate Program. In addition, six of her direct reports completed the program.

Harminder Sikand, Pharm.D., FCSHP, FASHP, clinical director and residency director at Scripps Mercy Hospital, was recently elected as president of the San Diego Society of Health-System Pharmacists.

  

Update: Issues of Interest to Membership

Provided by: Curtis Haas, Pharm.D., BCPS; and Stacy Voils, Pharm.D., BCPS

BPS Approves Critical Care Pharmacy as New Specialty BPS has announced the approval of critical care pharmacy as a new specialty. The approval of pediatric pharmacy as a specialty was announced at the same time (see related article on page 3). As most of you know, BPS conducted a role delineation study of critical care pharmacy practice and subsequently issued a request for petition last year. ACCP, ASHP, and APhA collaborated on developing the petition that was submitted to BPS in November 2012. BPS held open hearings regarding the petition at the Midyear Clinical Meeting, a transcript of which is available at the BPS Web site ().

Medicare benefit initiative to recognize clinical pharmacists’ direct patient care services (“provider status”)

Last December, ACCP announced the launch of a formal initiative to pursue recognition of direct patient care (DPC) services by clinical pharmacists as a covered benefit under the Medicare program (www.accp.com/report/?iss=1212&art=1). The framework of this initiative should resonate well with critical care pharmacists because it is focused on DPC (assessment of patients and their pharmacotherapy needs; initiation, modification, or discontinuation of patient-specific drug therapy; and ongoing monitoring and follow-up) as members of a team providing interdisciplinary patient care. This is the essence of the model of the clinical pharmacist’s role as a member of the critical care patient care team, which the specialty has embraced for more than 2 decades. As our health care delivery system evolves under health care reform, it is more important than ever that clinical pharmacy and the value we bring to patient care are recognized by CMS (Centers for Medicare & Medicaid Services) and other payers. Because fee-for-service reimbursement, as we know it, is going away, it is difficult to know what might evolve as the financial impact of “provider status,” but it is important that clinical pharmacy have a “seat at the table” in a reformed system of health care delivery. It is also imperative that we articulate that this initiative is not about pharmacy or pharmacists, but about patients. We believe the active engagement of clinical pharmacists on the patient care team improves quality and outcomes by “getting the medications right.”

ACCP has retained the Federal Group, a Washington consulting firm with a track record in lobbying, for provider recognition. The Federal Group will provide strategic government relations and advocacy services to assist ACCP in pursuing this goal. It will be a potentially long and challenging path to travel, but ACCP has defined this as our most important policy and advocacy agenda item. Please take a few minutes and read the related articles in the December and January ACCP Reports, which include an FAQ document to help clearly define the goals and principles underlying this effort.

Student Chapter Recognition

For those of you in academia (or students), the Board of Regents  made an important announcement after the October board meeting. ACCP has decided to create a mechanism for the formal recognition of student chapters. Students make up the fastest-growing membership category in ACCP, and the student members have made it clear to the board that recognition of student chapters on school campuses is very important to them. At the request of the Board of Regents, ACCP staff are currently working on the details of chapter recognition, which should be made public sometime later this year, together with the time line for implementation. This creates an exciting opportunity to spread the word about the benefits of ACCP membership to more students and to offer options for local engagement in a chapter of a national pharmacy organization that is focused on developing, advancing, and positioning clinical pharmacists. The number of student chapters is expected to increase steadily in the next few years, which will further promote the growth of our student membership. This is not only great for the current vitality of the organization, but is also an investment in the future of the organization and the discipline of clinical pharmacy.

Awards

Congratulations to the recipients of the following awards, presented at the 2012 ACCP Annual Meeting.

Asad (Sid) Patanwala, Pharm.D., BCPS: ACCP New Clinical Practitioner Award

Ishaq Lat, Pharm.D., FCCP, FCCM, BCPS: Critical Care PRN Education Award

Douglas Fish, Pharm.D., FCCP, FCCM: Critical Care PRN Research Award

Alley Killian, Pharm.D., BCPS: Critical Care PRN Clinical Practitioner Award

Judith Jacobi, Pharm.D., FCCP, FCCM, BCPS, DPNAP: Critical Care PRN Achievement Award

Sara Jordan, Pharm.D.: Critical Care PRN Young Investigator Travel Award

Bryan Lizza, Pharm.D.: Critical Care PRN Resident/Fellow Travel Award

New Committee Update

Provided by: Pamela Smithburger, Pharm.D., BCPS

During the 2012 ACCP Annual Meeting in Hollywood, Florida, the PRN membership voted to create a newly formed research committee. The newly formed research committee’s charges include (1) developing a funding mechanism to support a Critical Care PRN member’s participation in the ACCP FIT program, (2) developing and implementing a PGY2 research grant, and (3) developing and implementing a Critical Care PRN Member Research Grant. Those who are interested in helping to complete the charges of the new committee or those with questions can contact Pam Smithburger by e-mail ([email protected]).

 

Awards

• May DW, Norman C, Gomez TA. Outstanding Health-System Newsletter Award. Georgia Society of Health-System Pharmacists; October 2012; Young Harris, GA. 

Grants

• Freeman MK, Hughes PJ, Slaton RM. Samford University Global Drug Information Service – Birmingham, Alabama.;

            Alabama Alliance for Nursing Facility Quality and Care Coordination –   Funding Opportunity No. CMS-1E1-12-002 [Initiative to Reduce Avoidable Hospitalizations Among Nursing Facility Residents]. U.S. Department of Health and Human Services, Centers for Medicare & Medicaid Services, Medicare and  Medicaid Coordination Office, Center for Medicare & Medicaid Innovation. Collaboration with Alabama Quality Assurance Foundation (AQAF), The University of Alabama at Birmingham, Samford University, and Alabama Department of Senior Services. Principal investigator: Liz Prosch, RN, MSHA, LNHA.

      Status: Funded

      Role: Coinvestigators

      Grant Amount: $15,000,000. September 2012

• Gettig JP. 1st Annual Update in Diabetes Management and Education. Submitted to Amylin Pharmaceuticals for $10,250. Awarded $5000. February 2012.
• Gettig JP. 1st Annual Updates in Diabetes Management and Education. Submitted to Novo Nordisk, Inc., for $10,250. Awarded $7500. February 2012.
• Gettig JP. 1st Annual Updates in Diabetes Management and Education. Submitted to Merck & Co., Inc., for $10,250. Awarded $5000. February 2012.
• Ward K. Addressing Educational and Coordination Barriers for Adult Pneumococcal Disease Prevention in Rhode Island.

Role: Coinvestigator

Funding Source: Pfizer Medical Education Group

Funding Amount: $703,993

 

Publications

• Cole SW, Lundquist LM. Icatibant for the treatment of hereditary angioedema. Ann Pharmacother 2013;47:49-55.
• Shannon JA, Cole SW. Pegloticase: a novel agent for treatment-refractory gout. Ann Pharmacother 2012;46:368-76.
• Lundquist LM, Cole SW, Augustine JM. Critical appraisal of efficacy and safety of abatacept in the treatment of refractory rheumatoid arthritis. Open Access Rheumatol Res Rev 2012;4:9-19.

• Forehand CF, Cribb J, May JR. Examination of the relationship between antimicrobials and thrombocytosis. Ann Pharmacother 2012;46:1425-9.
• Fox ER, Tyler LS. Call to action: finding solutions for the drug shortage crisis in the United States. Clin Pharmacol Ther 2013;93:145-7.
• Gabay MP, Thakkar JP, Stachnik JM, Woelich SK, Villano JL. Intra-CSF administration of chemotherapy medications. Cancer Chemother Pharmacol 2012;70:1-15.
• Gabay M. Tech-check-tech: an overview. Hosp Pharm 2012;47:444-5.
• Gabay M. Drug importation: where do we stand? Hosp Pharm 2012;47:110-1.
• Freeland KN, Cogdill BR, Ross CA, Sullivan CO, Drayton SJ, VandenBerg AM, Short EB, Garrison KL. Adherence to evidence-based treatment guidelines for bipolar depression in an inpatient setting. J Health Syst Pharm Res. 2012;1(1). Available online.
• Miller D, Garcia D, Jade-Kreys T, Phan S, VandenBerg A, Garrison KL. Evaluation of the quality of medication reconciliation obtained upon hospital admission. Hosp Pharm 2012;47:526-31.
• Gettig JP. Application process – the holiday rush. In: Bookstaver PB, Caulder CR, Smith KM, et al. Roadmap to Postgraduate Training in Pharmacy. New York: McGraw-Hill, 2013:139-61.
• Giouroukakis M, Dryer M. Unapproved drugs—the drug information pharmacists’ perspective. J Pharm Pract. 2013 Mar 4.
• Shepherd G, Mohorn P, Yacoub K, May DW. Adverse drug reaction deaths reported in United States vital statistics, 1999-2006. Ann Pharmacother 2012;46:169-75.
• Cooley TW, May DW (corresponding author), Alwan M, Sue C. Implementation of computerized prescriber order entry in four academic medical centers. Am J Health Syst Pharm 2012;69:2166-4. 
• May DW, Chisholm-Burns MA. Gastroesophageal reflux disease. In: Chisholm-Burns MA, Wells BG, Schwinghammer TL, Malone PM, Kolesar JM, DiPiro JT, eds. Pharmacotherapy Principles & Practice, 3rd ed. New York: McGraw-Hill, 2013:333-44.
• Bourg CA, Gregg EL, May DW. Peptic ulcer disease. In: Chisholm-Burns MA, Wells BG, Schwinghammer TL, Malone PM, Kolesar JM, DiPiro JT, eds. Pharmacotherapy Principles & Practice, 3rd ed. New York: McGraw-Hill, 2013:345-58.
• May JR, Chan J, Choudhary K, et al. Coping with the residency scramble. Am J Health Syst Pharm 2012;69:253-5.
• May JR, Smith PH. Drug allergies and pseudoallergies. In: Pharmacotherapy Principles & Practice, 3rd ed. New York: McGraw-Hill, 2013:965-76.
• Phillips JA, Gabay MP, Ficzere C, Ward KE. Curriculum and instructional methods for drug information, literature evaluation, and biostatistics: a survey of US pharmacy schools. Ann Pharmacother 2012;46:793-801. 

Other Notable Achievements

• Gettig JP. Selected as a fellow in the AACP Academic Leadership Fellows Program (ALFP) for 2012–2013.
• May JR. Presented the following topics at the Clinical Symposium, Misr International University; November 2012; Cairo, Egypt:
• “Foundations of Antimicrobial Stewardship”
• “New Drug Update 2012: A Formulary Approach”
• May JR, May DW. Conducted “Systematic Approach to Drug Information,” a 4.5-hour workshop for hospital pharmacists at Misr International University. This workshop was in response to the Egyptian Ministry of Health’s decision to make drug information centers in Egyptian hospitals mandatory.
• May JR. Worked with University of Georgia College of Pharmacy students to establish the Student Diabetes Club as an official organization at the university. Named faculty adviser for the organization. A drug information newsletter for diabetes called Diabetes in Focus is the official publication for this group.
• Cole SW, Hanrahan CT. Assessment of drug information resource preferences by pharmacy students and faculty [abstract 48]. Pharmacotherapy 2012;32:e191. [Poster Presentation]

 

The Education and Training PRN (EDTR) has grown to more than 450 members who continue to advance the PRN’s mission of promoting dialogue and interaction to develop programs that enhance the knowledge and skills needed to provide education and training within clinical pharmacy. The PRN is happy to share the many accomplishments of its members and looks forward to another productive year.

The EDTR once again hosted the mock interviews for students and residents during the 2012 ACCP Annual Meeting. Sixty interviewees took advantage of this opportunity to learn key interviewing skills from clinical faculty and practitioners in preparation for residency or initial career position interviews. Forty-two interviewers graciously volunteered their time to make this event a success. Most participants were able to go through two or three rounds of mock interviews to receive valuable feedback from several interviewers.

 During the EDTR business meeting, members also had the opportunity to hear from Janet Teeters, director of accreditation services at ASHP, who provided a very informative update regarding changes to pharmacy-specific duty hours, board certification required for PGY2 residency program directors, the post-Match process, and PhORCAS (Pharmacy Online Residency Centralized Application).

 Our Scholarly Activities Committee is continuing its work on a book that will offer useful teaching tips for clinical faculty and preceptors. A special thanks to Tina Denetclaw for her continued leadership on this important project.

 At the upcoming ACCP Spring Updates in Therapeutics^® meeting in Reno, Nevada, the EDTR will host a networking breakfast on Sunday, April 21, from 7:30 a.m. to 9:00 a.m. This will provide a good opportunity to meet informally with other PRN members to exchange ideas related to teaching and learning.

 The EDTR is proud of its growing membership and would like to continue expanding. We encourage ACCP members who are interested in promoting our mission to join the EDTR PRN.

Promotions

Haley Phillippe, Pharm.D., BCPS: Dr. Phillippe will be promoted to associate clinical professor at Auburn University Harrison School of Pharmacy (AUHSOP) in the fall.

T. Lynn Stevenson, Pharm.D., BCPS: Dr. Stevenson will be promoted to associate clinical professor at Auburn University Harrison School of Pharmacy (AUHSOP) in the fall.

Awards

Katie S. McClendon, Pharm.D., BCPS, was honored by the Mississippi Board of Trustees of State Institutions of Higher Learning as the University of Mississippi Medical Center’s 2013 Diversity Educator of the Year.

Grants

Rebecca B. Sleeper Irons, Pharm.D., FCCP, FASCP, BCPS, received a grant ($25,000) from the Laura Bush Institute for Women’s Health for the initial phase of a collaboration between the schools of pharmacy, nursing, and medicine to audit and map existing curricular content/delivery related to sex- or gender-based medicine at Texas Tech University Health Sciences Center (TTUHSC) with the goal of evaluating and enhancing the delivery of gender-specific content in health professions curricula.

Samantha Karr, Pharm.D., BCPS, BCACP, was awarded an intramural grant by the Midwestern University College of Pharmacy-Glendale for $2830 for research titled, “Assessing Accuracy and Impact on Clinical Decision-making of Community-Based Blood Pressure Monitoring.”

Publications

Michael J. Peeters, Pharm.D., M.Ed., BCPS

Vaidya V, Peeters MJ, Partha G, Potnis P. Evaluating the association between type of prescription drug plan and asthma patients’ use of controller medications. J Pharm Health Serv Res 2012;3:65-9.

Serres ML, Peeters MJ. Overcoming content specificity in admission interviews: the next generation? Am J Pharm Educ 2012;76:Article 207.

Gundrum TE, Serres ML, Peeters MJ. Reliability of an approach to pharmacy resident selection. Abstract presented at: ASHP Midyear Meeting; December 5, 2012; Las Vegas, NV.

Peeters MJ, Cox CD. A pilot in peer observation of clinical teaching. Abstract presented at: Conference Proceedings of the Professional and Organizational Development Network; 2012.

Hoover M, Jacobs D, Jung R, Peeters MJ. Validity and reliability with educational testing in the pharmacy and medical literature [abstract]. Pharmacotherapy 2012;32(10).

Sarah A. Nisly, Pharm.D., BCPS

Nisly SA, Kolanczyk D, Walton AM. Canagliflozin, a new sodium-glucose co-transporter 2 inhibitor, in the treatment of diabetes. AJHP 2013;70:311-9.

Axford K, Dy E, Nisly SA. Lipid goals: update on their status. Indiana Pharmacists Alliance (IPA) continuing pharmacy education (CPE). 2012;8:1-8.

Katie S. McClendon, Pharm.D., BCPS

McClendon KS. Phentermine/topiramate ER (Qsymia): second new obesity medication approved in 2012 [update]. In: Talbert RL, DiPiro JT, Matzke GR, Posey LM, Wells BG, Yee GC, eds. Pharmacotherapy: A Pathophysiologic Approach, 8th ed. New York: McGraw-Hill, 2012. www.accesspharmacy.com/updatesContent.aspx?aid=4000240.

McClendon KS. Lorcaserin approved for treatment of obesity [update]. In: Talbert RL, DiPiro JT, Matzke GR, Posey LM, Wells BG, Yee GC, eds. Pharmacotherapy: A Pathophysiologic Approach, 8th ed. New York: McGraw-Hill, 2012. www.accesspharmacy.com/updatesContent.aspx?aid=4000198.

Amy Tiemeier, Pharm.D., BCPS

Grice GR, Gattas NM, Sailors J, Murphy JA, Tiemeier AM, Hurd P, Prosser T, Berry T, Duncan W. Health literacy: use of the Four Habits Model to improve student pharmacists’ communication. Patient Educ Couns 2013;90:23-8.

Cain J, Scott DR, Metzger A, Tiemeier AM. Social media use by pharmacy faculty: student friending, e-professionalism, and professional use. Curr Pharm Teach Learn 2013;5:2-8.

Vouri SM, Tiemeier AM. The ins and outs of pharmacy services at a Program of All-inclusive Care for the Elderly (PACE) organization. Consult Pharm 2012;27:803-7.

Sandra Benavides, Pharm.D.; and Joshua Caballero, Pharm.D., BCPP

Caballero J, Wolowich WR, Benavides S, Marino J. Difficulty and discrimination indices of multiple-choice examinations in a college of pharmacy pathophysiology and therapeutics course sequence. Int J Pharm Pract. 2013. [Epub ahead of print]

Sandra Benavides, Pharm.D.

Dr. Benavides served as lead editor in the first pediatric textbook, Pediatric Pharmacotherapy, available through the ACCP Bookstore. The book includes 53 peer-reviewed chapters on common pediatric diseases. Dr. Benavides also wrote two chapters on diabetes and obesity (Benavides S, Nahata MC, eds. Pediatric Pharmacotherapy. Lenexa, KS: American College of Clinical Pharmacy, 2012).

Presentations

Beth H. Resman-Targoff, Pharm.D., FCCP

Resman-Targoff B. Their own worst enemy: helping patients with autoimmune diseases. Paper presented at: American Pharmacist Association (APhA) Annual Meeting; March 2013; Los Angeles, CA.

Lori B. Hornsby, Pharm.D., BCPS

Hornsby L. Update in venous thromboembolism. Paper presented at: Alabama Pharmacy Association Midwinter Conference; February 2013; Auburn, AL.

New ACCP Fellows

Recently inducted at the ACCP Annual Meeting in October 2012:

Amie D. Brooks, Pharm.D., BCPS (St. Louis College of Pharmacy)

Shareen El-Ibiary, Pharm.D., BCPS (Midwestern University, College of Pharmacy-Glendale)

Kristi Kelley, Pharm.D., BCPS, CDE (Auburn University, Harrison School of Pharmacy)

Julie Kissack, Pharm.D., BCPS (Harding University, College of Pharmacy)

Julie Murphy, Pharm.D., BCPS (The University of Toledo)

Susan Winkler, Pharm.D., BCPS (Midwestern University, College of Pharmacy Chicago)

Other Notable Achievements

Jennifer Clements, Pharm.D., BCPS, CDE: Dr. Clements is now an associate professor of pharmacy practice at Presbyterian College School of Pharmacy.

Lynn Radonic Patton, RPh, M.S., BCNSP: Dr. Patton is president of the Arizona Society for Parenteral and Enteral Nutrition (AzSPEN).

 Christina M. Madison, Pharm.D., BCACP: Dr. Madison is serving a 1-year term as president of Nevada Public Health Association. She is one of only two pharmacists in the country to hold this position in a public health association.

 

Current Officers:

Chair: Nicole M. Acquisto, Pharm.D., BCPS

Chair-Elect: Mary Beth Shirk, Pharm.D., BCPS

Secretary/Treasurer: Megan Musselman, Pharm.D., BCPS

 Please stop by the Emergency Medicine PRN (EMED PRN) table during the ACCP networking breakfast on Saturday, April 20, 2013, 7:30 – 9:00 a.m., at the Peppermill Resort, Reno, Nevada, as part of the series of networking breakfasts during ACCP’s Updates in Therapeutics^®.

The EMED PRN would like to acknowledge and congratulate all of its members on their accomplishments and achievements.

Awards

• Zlatan Coralic, Pharm.D.: Pharmacy Practice Residency Preceptor of the Year 2012 – University of California – San Francisco. 

Grants

• Zlatan Coralic, Pharm.D.: ASHP Foundation 2012 New Investigator Research Grant.
• Kevin O. Rynn, Pharm.D., FCCP, DABAT: Awarded a $50,000 Community Pharmacy Residency Expansion Project (PREP) grant to be distributed over 3 years from the NACDS foundation in support of residency program expansion. 

Publications

Nicole M. Acquisto, Pharm.D., BCPS:

• Kamali MF, Wilson AC, Acquisto NM, Spillane L, Schneider SM. Acute encephalopathy with concurrent respiratory and metabolic disturbances in first known parenteral human administration of flunixin meglumine and acepromazine maleate. J Emerg Med 2012. Accepted for e-publication.
• Fabiano SE, Acquisto NM. Evaluation of methods of education for emergency medicine providers and utilization in daily practice. Paper presented at: 47th Annual American Society of Health-System Pharmacists. Midyear Clinical Meeting and Exhibition; December 5, 2012; Las Vegas, NV.
• Bucklin M, Rosenblum T, Crowley A, Leonhardt AM, Acquisto NM. Effect of continuous infusion versus intermittent administration of antihypertensive medications on time to goal blood pressure in patients with acute stroke. The 47th Annual American Society of Health-System Pharmacists Midyear Clinical Meeting and Exhibition; December 5, 2012; Las Vegas, NV.
• Bucklin M, Rosenblum T, Crowley A, Leonhardt AM, Acquisto NM. Effect of continuous infusion versus intermittent administration of antihypertensive medications on time to goal blood pressure in patients with acute stroke. United HealthSystem Consortium Annual Meeting; December 2012; Las Vegas, NV.
• Groth CM, Acquisto NM. Pharmacists as members of the rapid response team. American College of Clinical Pharmacy Annual Meeting; October 2012; Hollywood, FL. Pharmacotherapy 2013;32:966.
• Phillips MA, Acquisto NM, Gorodetsky RM, Wiegand TJ. Physostigmine continuous infusion for the treatment of anticholinergic toxicity in combined diphenhydramine and bupropion overdose. Annual Meeting of the North American Congress of Clinical Toxicology; October 2012; Las Vegas, NV.

Katelyn R. Dervay, Pharm.D., BCPS:

• Adams D, Dervay K. Pharmacology of procedural sedation. AACN Adv Crit Care 2012;23:355-6.

Darrel W. Hughes, Pharm.D., BCPS:

• Hughes DW, Attridge RL. Advanced cardiac life support. In: Attridge, Miller, Moote, Ryan, eds. Internal Medicine: A Guide to Clinical Therapeutics. New York: McGraw-Hill, 2013.
• Hughes DW. Antidotes appendix. In: Attridge, Miller, Moote, Ryan, eds. Internal Medicine: A Guide to Clinical Therapeutics. New York: McGraw-Hill, 2013.
• Duhon B, Franco-Martinez AC, Maxwell PR, Attridge RL, Hughes DW. Intravenous sodium bicarbonate therapy in severely acidotic diabetic ketoacidosis. Ann Pharmacother 2013. In press.
• Caballero GC, Hughes DW, Gamboa C, Maxwell P, Green K, Barthol C. Levetiracetam compared to phenytoin for seizure prophylaxis following traumatic brain injury: a retrospective review. Hosp Pharm 2013. In press.

 Megan Musselman, Pharm.D., BCPS:

• Musselman M, Saely S. Drug-induced hyperthermia: diagnosis and treatment. Am J Health Syst Pharm 2013;70:34-42.
• Wilson RF, Atkinson BE, Flynn LM, Musselman M, Hall Zimmerman L. Cardiovascular anatomy and physiology. In: Asensio, Trunkey, eds. Current Therapy for Trauma and Critical Care, 2nd ed. Philadelphia: Elsevier. In press.
• Musselman M, Lucas AJ, Robke JT. Survey assessment of pharmacy resident and preceptor perceptions of feedback. Paper presented at: 47th Annual ASHP Midyear Clinical Meeting; December 4, 2012; Las Vegas, NV.

Asad (Sid) Patanwala, Pharm.D., BCPS:

• Patanwala AE. PGY2-acute care medicine. In: Bookstaver et al., eds. Roadmap to Postgraduate Training in Pharmacy. New York: McGraw-Hill, 2013:273-85.
• Mosier J, Chiu S, Patanwala AE, Sakles JC. A comparison of the GlideScope video laryngoscope to the C-MAC video laryngoscope for intubation in the emergency department. Ann Emerg Med. 2013 Jan 29.
• Patanwala AE, Jasiak KD, Christich AC, Edwards CJ, Phan H, Snyder EM. Age-related differences in propofol dosing for procedural sedation in the emergency department. J Emerg Med. 2013 Jan 16.
• Patanwala AE, Holmes K, Erstad BL. Analgesic response to morphine in obese and morbidly obese patients in the emergency department. Emerg Med J. 2013 Jan 12.
• Amini A, Patanwala AE, Maegawa FB, Skrepnek GH, Jie T, Gruessner RW, Ong ES. Effect of epidural analgesia on postoperative complications following pancreaticoduodenectomy. Am J Surg 2012;2004:1000-4.
• Watt J, Amini A, Traylor B, Amini R, Sakles JC, Patanwala AE. Effect of paralytic type on time to post-intubation sedative use in the emergency department. Emerg Med J. 2012 Nov 8.
• Erstad BL, Patanwala AE, Theodorou AA. Comparison of methods for the detection of medication safety events in the critically ill. Curr Drug Saf 2012;7:238-46.

Suprat Saely, Pharm.D., BCPS:

• Musselman ME, Saely S. Diagnosis and treatment of drug-induced hyperthermia. Am J Health Syst Pharm 2013;70:34-42.

 Kyle Weant, Pharm.D., BCPS:

• Mason MA, Weant KA, Baker SN. Rapid sequence intubation medication therapies: a review in light of recent drug shortages. Adv Emerg Nurs J 2013;35:16-25.
• Weant KA, Baker SN. Review of human rabies prophylaxis and treatment. Nurs Clin North Am 2013. In press.
• Weant KA, Baker SN. Emergency medicine pharmacists and sepsis management. J Pharm Pract 2012. In press.
• Defrates SR, Weant KA, Seamon JP, Shirakbari A, Baker SN. Emergency pharmacist impact on health care-associated pneumonia empiric therapy. J Pharm Pract 2012. In press.
• McConeghy KW, Winstead PS, Cook AM, Martin CA, Weant KA, Flynn JD. Benefits of a 24-hour inhouse on-call program for pharmacy residents. AJHP 2012;69:2150-64.

Presentations/Posters

• Nicole M. Acquisto, Pharm.D., BCPS: Presented an emergency medicine clinical pearl, “Physostigmine: it’s back,” at the ASHP Midyear Clinical Meeting; December 5, 2012; Las Vegas, NV.
• Craig Cocchio, Pharm.D., BCPS:  Evolving trends in the acute management of traumatic brain injury. Presented as: part of the Emergency Medicine PRN Focus Session—Traumatic Emergencies: Blood, Brain, and Bacteria. ACCP Annual Meeting; October 22, 2012; Hollywood, FL.
• Megan Musselman, Pharm.D., BCPS: Attack of the killer migraine: droperidol to the rescue. Presented as: ACPE CE lecture, part of the ASHP Midyear Clinical Meeting to Pharmacists, Pharmacy Residents, and Pharmacy Technicians; December 5, 2012; Las Vegas, NV.

Toxicologic emergencies. Presented as an ACPE CE lecture, part of the KCHP/MSHP Annual Meeting to Pharmacists, Pharmacy Residents, and Pharmacy Technicians; April 20, 2012; Kansas City, MO.

• Suprat Saely, Pharm.D., BCPS:  Moore D, Saely S, Jennett-Reznek AM, Courage CA, Sherwin RL. Short-term use of neuromuscular blocking agents in post rapid sequence intubation patients are not harmful, and may be beneficial! Paper presented at: American College of Emergency Physicians Research Forum; October 8, 2012; Denver, CO.

Kwiatkowski GM, Saely S, Purakal J, Mahajan A, Levy PD. Nitroglycerin for treatment of acute, hypertensive heart failure: bolus, drip or both? Paper presented at: American College of Emergency Physicians Research Forum; October 9, 2012; Denver, CO.

Other Notable Achievements

• Cristy Pounders Singleton, Pharm.D., CPP: Established a collaborative practice agreement with Carolina Mountain Emergency Medicine physician group as a clinical pharmacist practitioner at Mission Hospital, Asheville, NC.
• Adam Landers, Pharm.D., BCPS, CPP: Established a collaborative practice agreement with Carolina Mountain Emergency Medicine physician group as a clinical pharmacist practitioner at Mission Hospital, Asheville, NC.
• Bethany Strickland Delk, Pharm.D., BCPS, CPP: Established a collaborative practice agreement with Carolina Mountain Emergency Medicine physician group as a clinical pharmacist practitioner at Mission Hospital, Asheville, NC. 

EMED PRN Committee Activities

• CODE (the Collaborative Organization for Development of Emergency Medicine Pharmacists) Committee – Samantha Bastow, Pharm.D. (Chair):
  

  Looking to expand your current emergency medicine pharmacy practice? Interested in sharing ideas to further pharmacy as a profession? Look no further!

  We wanted to remind you of the exciting opportunity to join the EMED PRN CODE Program. The Collaborative Organization for Development of Emergency Medicine Pharmacists (CODE Program) encourages idea sharing and fosters professional growth by forming meaningful partnerships among emergency medicine pharmacists. Biannually, the program will match participants on the basis of personally identified strengths and goals, as indicated on the registration form.

  To participate, simply complete the Participant Bio found on the EMED PRN homepage under PRN Documents/CODE Program Documents/Bio for CODE Program Participant. All members are encouraged to join. We hope this will be a great tool for us to work together to advance our practice.

• Educational Programming Committee – Mary Beth Shirk, Pharm.D., BCPS (Chair):
  

  The Programming Committee is developing the EMED PRN focus session for the 2013 ACCP Annual Meeting in Albuquerque, New Mexico. The title of the session will be “The Great Disappearing Act: Drug Shortages and Emergency Medicine.” This educational session will focus on the resurgence of medications used in emergency medicine and other acute care settings driven by ongoing drug shortages.

• Media Committee – Craig Cocchio, Pharm.D., BCPS (Chair):
  

  The Media Committee is currently working on a spring newsletter that will feature two clinical topic reviews. The topics selected include a review of tranexamic acid and the CRASH-2 studies by two current emergency medicine PGY2 residents (Ruben Santiago, Pharm.D., and Nadia Awad, Pharm.D.) as well as a discussion surrounding the use of t-PA in patients taking dabigatran, rivaroxaban, or apixaban (Brittany L. Riley, Pharm.D., BCPS, and Brooke Bitner, Pharm.D., BCPS). The targeted release date for this newsletter is April 2013.

• Travel Award Committee – Nicole M. Acquisto, Pharm.D., BCPS (Chair):
  

  The Travel Award Committee will give two awards this year to help support the costs of travel and attendance at the 2013 ACCP Annual Meeting. A call for abstracts and details of award requirements will be sent to EMED PRN members in August.

 

The Endocrine and Metabolism PRN is composed of members from a variety of practice settings. The PRN was formed to achieve the following goals and objectives: (1) provide an opportunity for pharmacists with an interest in endocrine and metabolism disorders to promote practice, research, and education in these areas; (2) provide a mechanism for members with similar interests to meet during ACCP meetings to network, problem solve, and discuss professional issues and opportunities; and (3) promote practice involvement; educational needs of health care professionals, students, and patients; and research activities in the areas of endocrinology and metabolism that may be favorably affected by this ACCP PRN effort.

During the past 6 months, some notable member accomplishments are as follows.

Awards

• Krystal L. Edwards: Texas Tech University Health Sciences Center President’s Outstanding Clinician Award.
• Brian K. Irons: Texas Tech University Health Sciences Center 2012 President’s Excellence in Interprofessional Teamwork Award.
• Nathan A. Painter: Cardinal Health Generations Rx Champion Award from the California Pharmacists Association (CPhA). This award recognizes a pharmacist who has demonstrated excellence in community-based prescription drug abuse prevention. 

Grants

• Nicole R. Pinelli (Principal Investigator). Intravenous Exenatide Infusion in Critically Ill Neurologic Injured Patients: A Proof of Concept Study. Funded, Bristol-Myers Squibb. 

Publications

• Jennifer Goldman-Levine
  • Goldman-Levine JD, Patel D, Schnee D. Insulin degludec: a novel insulin analogue. Ann Pharmacother 2013;47:269-77.
  • Patel D, Goldman-Levine JD. Fidaxomicin (Dificid) for Clostridium difficile. Am Fam Physician 2013;87:211-2.
  • Goldman-Levine JD, Dvorkin CL. Patented medicine (complementary and alternative medicine for the treatment of type 2 diabetes). Diabetes Self Manage 2012;Sept/Oct:42-3.
• Brian Irons
  • Irons B. New pharmacotherapies for type 2 diabetes. In: Murphy J, Lee M, eds. Pharmacotherapy Self-Assessment Program, 2013 Book 1. Cardiology and Endocrinology. Lenexa, KS: American College of Clinical Pharmacy, 2013:5-25.
• Nathan A. Painter
  • Painter NA, Morello CM, Singh RF, McBane SE. An evidence-based and practical approach to using Bydureon™ in patients with type 2 diabetes. J Am Board Fam Med 2013;26:203-10.

• Devada Singh-Franco
  • Singh-Franco D, Perez A, Wolowich W. Improvement in surrogate endpoints by a multidisciplinary team in a mobile clinic serving a low-income, immigrant minority population in South Florida. J Health Poor Underserved 2013;24:67-77. 

Research Abstracts – Published in Academic Journals

• Nicole R. Pinelli
  Ingemi I, Rech M, Fleming J, Pinelli NR, Moore C. 25-Hydroxy vitamin D status and the incidence of acute cellular rejection in kidney transplant recipients. J Am Soc Nephrol 2012;23:351A. Poster presented at: 2012 American Society of Nephrology Meeting; November 2012; San Diego, CA.

Presentations

• Jennifer Goldman-Levine
  • Evidence-based treatments for diabetic peripheral neuropathy. New Hampshire Pharmacists Association; March 2013 (1CE).
  • Barriers to insulin use and insulin pump use. Two-hour workshop presented to: pharmacists, physicians, nurses, clinical staff, and marketing staff. Becton Dickenson; January 2013; Billerica, MA.
  • T2DM 2012: Expert recommendations & evidence-based strategies for achieving optimal results; focus on the newer agents. Presented to: pharmacists and nurses at the Cardiovascular Clinical Update Continuing Education Conference on behalf of MSHP; November 2012; Westford, MA. (1CE)
  • Complications of diabetes: the management and impact on patients. Paper presented to pharmacists at: NHSHP 30th Annual Autumn Continuing Education Seminar; October 12, 2012; Concord, NH. (1.5CE)
  • More creative techniques to engage your audience in active learning. Two-hour workshop to pharmacists, presented at: ASHP Midyear Clinical Meeting; December 5, 2012; Las Vegas, NV. (2CE)
  • Goldman-Levine JD, Cook T. Active learning techniques for teaching in the pharmaceutical sciences. Two-hour workshop to pharmacists, scientists, academics, and researchers, presented at: AAPS Annual Meeting; October 2012; Chicago, IL. 

Other Notable Achievements

June Johnson served as item writer and on the Expert Review Panel for the BC-ADM examination (as a pharmacist member).

Marissa Quinones was recognized in the January 2013 ACCP Member Spotlight. She has been an active member of the Endocrine and Metabolism PRN for several years.

Resident Travel Scholarship

The Endocrine and Metabolism PRN Residency Travel Scholarship is intended to provide financial support for a resident-level member to attend the annual or spring ACCP meeting. The applicant must be a resident member (PGY1 or PGY2) in the ACCP Endocrine and Metabolism PRN. The applicant must provide a statement of why he or she is involved with the Endocrine and Metabolism PRN and describe how attending the meeting will assist in the applicant’s career and/or residency goals. A current copy of the applicant’s CV, highlighting professional organizations and community service, with one letter of recommendation are required for the complete application.

Congratulations to Dr. Sara Micale, an ambulatory care pharmacy practice resident at Albany College of Pharmacy and Health Sciences and The Endocrine Group, LLP, who will receive this year’s ACCP Endocrine and Metabolism PRN Resident Scholarship. She will receive $500 to attend the ACCP Updates in Therapeutics^® Meeting in Reno, Nevada, in April.

 

The Geriatric PRN wishes to acknowledge its members’ contributions to practice, scholarship, and teaching during the past 12 months.

Promotions

Virginia Skipper was promoted to Home-Based Primary Care Pharmacy Program Manager at the VA Puget Sound Healthcare System, Seattle, WA, in December 2012.

Awards

Allison B. Riendeau, 2012 AACP/Walmart Scholars Program Recipient, Jena L. Ivey Burkhart, Faculty Mentor

Grants/Research Funding

Jeff Hughes

2012    J.M. O’Hara Fund, PSWA. Correlation Between Vitamin D Levels and HbA1c and Inflammatory Markers in Aged Care Residents. $10,000

2012    Alzheimer’s Australia. Improving Pain Management Amongst Patients with Dementia. $50,000

2012    J.M. O’Hara Fund, PSWA. Investigation of Relationship of Calcium Channel Blockers and Male Urinary and Prostatic Health, Using Linked Data. $10,000

Jeannie Kim Lee

Title: Arizona Geriatric Education Center
Source: Department of Health and Human Services, Health Resources and Services Administration
Goal: To train health professionals throughout the state in the care of older adults
Role: Coinvestigator and member of interprofessional geriatric scholars; providing clinical pharmacy expertise and education related to pharmacology in aging, pharmacotherapy, and medication management and adherence
Amount: $2,100,000
Date: July 2012 – Present

Publications

Matthew Cantrell

1. Cantrell M, Argo T, Haak L, Janney L. Neuropsychiatric adverse effects associated with varenicline: a case series. Issues Ment Health Nurs 2012;33:665-9.
2. Cantrell M, Bream-Rouwenhorst HR, Watts C, Oetting TA. Pathophysiology and pre-operative evaluation of patients at risk for intraoperative floppy iris syndrome (IFIS). In: Zaidi FH, ed. Cataract Surgery. Rijeka, Croatia: InTech, 2013:chap 1.

Jeff Hughes

1. Jiwa M, Hughes JD, O’Connor M, Tuffin P. Field testing a protocol to facilitate the involvement of pharmacists in community based palliative care. Aust Pharm 2012;31:72-7.
2. Jiwa M, Meng X, Sririam D, Hughes JD, Colagiuri S, Twigg S, Skinner T, Shaw T. The management of type 2 diabetes: a survey of Australian general practitioners. Diabetes Res Clin Pract 2012;95:326-32.
3. Hughes J, Coniglio N, Protuder N, Stamatis E. The effect of proton pump inhibitors in increasing the risk of developing travellers’ diarrhoea – a literature review. Aust Pharm 2012;31:416-8.
4. Omar M, Crowe A, Parsons RW, Eh H, Tay CY, Hughes JD. P-glycoprotein expression in Helicobacter pylori positive patients: the influence of MDR1 (C3435T) polymorphism. J Dig Dis 2012;13:414-20.
5. Thompson AJ, Peterson GM, Jackson SL, Hughes JD, Redmond K. Utilizing community pharmacy dispensing records to disclose errors in hospital admission drug charts. Int J Clin Pharmacol Ther 2012;50:639-46.
6. Jiwa M, Hughes JD, Sririam D. Piloting and validating an innovation to triage patients presenting with cough to community pharmacies in Western Australia. Qual Prim Care 2012;20:83-91.
7. Hoti K, Hughes JD, Sunderland VB. Medication supply to residential aged care facilities in Western Australia using a centralized medication chart to replace prescriptions. BMC Geriatr 2012;12:1-6.
8. Hoti K, Hughes J, Sunderland VB. Identifying the perceived training needs for Australian pharmacist prescribers. Int J Pharm Pract. 2013 Jan 10. [Epub ahead of print] 

Jena L. Ivey Burkhart

Lauffenburger JC, Vu MB, Ivey Burkhart JL, Weinberger M, Roth MT. Design of a medication therapy management program for Medicare beneficiaries: qualitative findings from patients and physicians. Am J Geriatr Pharmacother 2012;10:129-38.

Carlos Rojas-Fernandez

1. Rojas-Fernandez CH, Mikhail M. Contemporary concepts in the pharmacotherapy of depression in older people [review]. Can Pharm J 2012;145:128-35.
2. Rojas-Fernandez CH, Cameron J. Is statin-associated cognitive impairment clinically relevant? A narrative review and clinical recommendations [narrative review]. Ann Pharmacother 2012;46:696-702.
3. Rojas-Fernandez CH, MacLaughlin EJ, Dore NL, Ebsary S. Assessing the potential adverse consequences of supplemental calcium on cardiovascular outcomes: should we change our approach to bone health [narrative review]? Ann Pharmacother 2012;46:549-57.

Jeannie Kim Lee

Amy Tiemeier

Other Notable Achievements

Mary Douzjian: Certified as BCPS.

Gregory J. Hughes: Assessment of medical resident drug information skills at an academic medical center. Paper presented at: Innovations in Drug Information Practice and Research session; ASHP Midyear Clinical Meeting; December 5, 2012; Las Vegas, NV.

Jeannie Kim Lee: Caring for older adults with disabilities. Media presentation at: UA BioMedical Communications, Interprofessional Education & Practice (IPEP) Disabilities Event; March 2012.

Jena L. Ivey Burkhart: Recertified for BCPS.

Deirdre P. Pierce: Certified as CGP.

Leslie Richard: Certified as CGP.

 

The GI/Liver/Nutrition PRN would like to acknowledge and congratulate the following members on their notable accomplishments.

Awards

April Smith received the Educator of the Year award from the fourth-year pharmacy student class at Creighton University School of Pharmacy and Health Professions.

Publications

1. Singh-Franco D, Perez A, Wolowich W. Improvement in surrogate endpoints by a multidisciplinary team in a mobile clinic serving a low-income, immigrant minority population in South Florida. J Health Poor Underserved 2013;24:67-77.
2. American College of Clinical Pharmacy (ACCP); Kirwin J, Canales AE, Bentley ML, Bungay K, Chan T, Dobson E, Holder RM, Johnson D, Lilliston A, Mohammad RA, Spinler SA. ACCP white paper: process indicators of quality pharmacist services in various types of transitions of care. Pharmacotherapy 2012;32:e338-47.
3. Mohammad RA, Regal R, Alaniz C. Combination therapy for the treatment and prevention of hepatic encephalopathy. Ann Pharmacother 2012;46:1559-63.

Other Notable Achievements

1. Lynn Radonic Patton was elected president of the Arizona Society for Parenteral and Enteral Nutrition.
2. April Smith was invited to speak at the ACCP 2012 Annual Meeting during the GI/Liver/Nutrition PRN session. The topic was “Medical Management of Chronic Disease in the Post-Bariatric Surgery Patient.”
3. April Smith was invited to speak at the American Society for Metabolic and Bariatric Surgery (ASMBS) Annual Meeting. The topics were “The Role of the Pharmacist on the Bariatric Surgery Team” and “Drug Absorption Issues Post-Bariatric Surgery.”
4. April Smith was invited to speak at the Alegent Health Bariatric Symposium. The topic was “Psychiatric Medication Use in the Bariatric Surgery Population.”
5. Juliana Chan became a Board Certified Ambulatory Care Pharmacist (BCACP).

 

Introduction

The Hematology/Oncology PRN facilitates the timely dissemination of information related to the clinical practice, research, and teaching of hematology and oncology among its members and serves as a resource for hematology and oncology expertise to others. The PRN provides a forum for hematology/oncology pharmacists to network and collaborate on scientific, educational, and political issues affecting clinical practice, teaching, and research.

Promotions

JoEllen L. Hanigosky, Pharm.D.; Clinical Coordinator, Hematology/Oncology/Bone Marrow Transplant, Akron Children’s Hospital, has been promoted to inaugural pharmacy research scholar for the children’s oncology group.

Grants

Jeannine S. McCune, Pharm.D.: Professor, University of Washington, and Associate Member, Fred Hutchinson Cancer Research Center. Principal investigator on the following grant: Pharmacogenetics of Cyclophosphamide ADRs in Children. 1 R21 CA162059-01A2.

Publications

John Bossaer, Pharm.D., BCPS, BCOP: Assistant Professor, Gatton College of Pharmacy, East Tennessee State University:

1. Bossaer JB, Lewis PO. Antibiotic use in home health: a primer. Home Health Care Manage Pract 2012;24:50-5.
2. Bossaer JB, Odle BL. Probable etoposide interaction with Echinacea. J Diet Suppl 2012;9:90-5.
3. Chakraborty K, Bossaer J, Patel R, Krishnan K. Successful treatment of nilotinib-induced pleural effusion with prednisone. J Oncol Pharm Pract. [Published online ahead of print November 15, 2012]
4. Bossaer JB, Cluck D. Home health care of patients with neutropenic fever. Home Health Care Manage Pract. [Published online ahead of print February 27, 2013]
5. Bossaer JB, Gray JA, Miller SE, Enck G, Gaddipati VC, Enck RE. The use (and misuse) of “cognitive enhancers” by students at an academic health sciences center: the elephant in the room. Acad Med. Accepted for publication.
6. Abu-Shahin FI, Bossaer JB, Enck RE. Soft tissue calcification secondary to imatinib mesylate in a patient with gastrointestinal stromal tumor (GIST). J Oncol Pharm Pract. Accepted for publication.

 

Niesha Griffith, RPh, M.S., FASHP: Director of Pharmacy and Infusion Services at the Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at The Ohio State University:

1. Frame JN, Jacobson JO, Vogel WH, Griffith NL, et al. Assessment of Risk-Evaluation and Mitigation Strategies in oncology: summary of the Oncology Risk Evaluation and Mitigation Strategies Workshop. J Oncol Pract. 2012 Oct 30. [Epub ahead of print]

 

Christy S. Harris, Pharm.D., BCPS, BCOP: Assistant Professor, Massachusetts College of Pharmacy and Health Sciences – Boston:

1. Harris CS, Wang D, Carulli A. Docetaxel-associated palmar-plantar erythrodysesthesia: a case report and review of the literature. J Oncol Pharm Pract. [Published online ahead of print March 11, 2013]
2. Cirrone F, Harris CS. Vismodegib and the hedgehog pathway: a new treatment for basal cell carcinoma. Clin Ther 2012;34:2039-50.

Pamala Jacobson, Pharm.D.: Associate Professor, Experimental and Clinical Pharmacology, College of Pharmacy, Minneapolis;

Book: New Edition Published – Jacobson, Senior Editor:

1. Alldredge BK, Corelli RL, Ernst ME, Guglielmo BJ, Jacobson PA, Kradjan WA, Williams BR, senior eds. Applied Therapeutics: The Clinical Use of Drugs, 10th ed. Philadelphia: Lippincott Williams & Wilkins, 2013.
2. Thyagarajan B, Jackson S, Basu S, Jacobson PA, Gross M, Weisdorf D, Arora M. Association between genetic variants in adhesion molecules and outcomes after hematopoietic cell transplantation. Int J Immunogenet. 2012 May 30. [Epub ahead of print]
3. Frymoyer A, Verotta D, Jacobson P, Long-Boyle J. Population pharmacokinetics of unbound mycophenolic acid in adult allogeneic hematopoietic cell transplantation: effect of pharmacogenetic factors. Br J Clin Pharmacol 2013;75:463-75.
4. Johnson LA, Tretyakova N, Jacobson PA. Obesity effects on cyclophosphamide-induced DNA damage in hematopoietic cell transplant recipients. In Vivo 2012;26:853-7.
5. Passey C,* Birnbaum A, Brundage R, Oetting W, Leduc R, Israni A, Guan W, Matas A, Jacobson PA. Validation of tacrolimus equation to predict troughs using genetic and clinical factors. Pharmacogenomics 2012;13:1141-7.
6. Kim H,* Long-Boyle J,* Rydholm N, Orchard PJ, Tolar J, Smith AR, Jacobson P, Brundage R. Population pharmacokinetics of unbound mycophenolic acid in pediatric and young adult patients undergoing allogeneic hematopoietic cell transplantation. J Clin Pharmacol 2012;52:1665-75.  K:  to here on second edit   
7. Jensen K,* Johnson LA, Jacobson PA, Kachler S, Kirstein MN, Lamba J, Klotz KN. Cytotoxic purine nucleoside analogues bind to A(1), A(2A), and A(3) adenosine receptors. Naunyn Schmiedebergs Arch Pharmacol 2012;385:519-25.
8. Johnson LA, Malayappan B, Tretyakova N, Campbell C, MacMillan ML, Wagner JE, Jacobson PA. Formation of cyclophosphamide-specific DNA adducts in hematological diseases. Pediatr Blood Cancer 2012;58:708-14.

*Designates a trainee at time of research.

Tali M. Johnson, Pharm.D., BCOP: Senior Clinical Research Pharmacist, Pharmaceutical Management Branch, CTEP/DCTD/NCI/NIH:

Johnson TM, Boron MJ. Early access to investigational agents through the National Cancer Institute’s Treatment Referral Center. J Hematol Oncol Pharm 2012;2:120-7.

Jeannine S. McCune, Pharm.D.: Professor, University of Washington, and Associate Member, Fred Hutchinson Cancer Research Center:

1. Li H, McCune JS, Salinger DH, Vicini P, Bemer MJ, Mager DE. Population pharmacokinetic model and limited sampling schedule for mycophenolic acid after IV mycophenolate mofetil administration in hematopoietic cell transplant recipients. J Clin Pharmacol 2012;52:1654-64.
2. McCune JS, Baker KS, Gamis A, Bemer MJ, Kelton-Rehkopf M, Barrett JS. Variation in prescribing patterns and therapeutic drug monitoring of intravenous busulfan in pediatric hematopoietic cell transplant recipients. J Clin Pharmacol 2013;53:264-75.
3. Chow EJ, Pihoker C, Friedman DL, Lee SJ, McCune JS, Wharton C, Roth CL, Baker KS. Glucocorticoids and insulin resistance in children with acute lymphoblastic leukemia. 2013;60:621-6.
4. Li H, Mager DE, Sandmaier BM, Maloney DG, Bemer MJ, McCune JS. Population pharmacokinetics and dose optimization of mycophenolic acid in HCT recipients receiving oral mycophenolate mofetil. J Clin Pharmacol. 2013 Feb 4:1-6. [Epub ahead of print]

Pamala A. Pawloski, Pharm.D.: Research Associate, HealthPartners Institute for Education and Research, Bloomington, MN:

1. Pawloski PA, Geiger AM, Haque R, Kamineni A, Fouayzi H, Ogarek J, Petersen HV, Bosco JLF, Thwin SS, Silliman RA, Field TS. Fracture risk in older, long-term survivors of early-stage breast cancer. J Am Geriatr Soc. Accepted for publication February 2013.
2. Cross D, Rahm AK, Kauffman TL, Webster J, Le AQ, Feigelson HS, Alexander G, Meier P, Onitilo A, Pawloski PA, Williams AE, Honda S, Daida YH, McCarty CA, Goddard KAB. Under-utilization of Lynch syndrome screening in a multisite study of colorectal cancer patients. Genet Med. Accepted for publication February 2013.
3. Webster J, Kauffman T, Feigelson HS, Pawloski P, Onitilo AA, Potosky AL, Cross D, Meier P, Mirabedi AS, Delate T, Daida Y, Williams A, Alexander GL, McCarty CA, Honda S, Kushi LH, Goddard KAB; on behalf of the CERGEN Study Team. KRAS testing and epidermal growth factor receptor inhibitor treatment for colorectal cancer in community settings. Cancer Epidemiol Biomark Prev. 2012 Nov 15. [Epub ahead of print]
4. Clough-Gorr KM, Thwin SS, Bosco JLF, Silliman RA, St. Charles M, Buist DSM, Pawloski PA, Quinn VP, Prout MN. Incident malignancies among older long-term breast cancer survivors and age-site-matched non-breast cancer comparisons over ten-years of follow-up. Cancer. 2012 Dec 26. [Epub ahead of print]
5. Dudek AZ, Kumar P, Thaw SSH, Cao Q, Pawloski P, Larson T. Phase II study of biweekly carboplatin, gemcitabine and bevacizumab as first-line treatment in patients with stage IIIB/IV NSCLC. Am J Clin Oncol. 2012 Oct 29. [Epub ahead of print]

New ACCP Fellow

David Baribeault, B.S., FCCP, BCOP: Clinical Adviser, Pharmacy Optimization, McKesson Health Solutions, Salem, MA.

Other Notable Achievements

Niesha Griffith, RPh, M.S., FASHP: Director of Pharmacy and Infusion Services at the Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at The Ohio State University, and the incoming HOPA president.

Pamala A. Pawloski, Pharm.D.: Research Associate, HealthPartners Institute for Education and Research. Her research proposal, titled “Colony-Stimulating Factor Use Among Cancer Patients in the Managed Care Setting,” was selected in February 2013 for the HMO Research Network Cancer Research (CRN) Scholars Program, a 26-month mentoring program aimed at using CRN resources for large-scale, multisite, population-based research. Eight investigator-initiated proposals were selected for this program.

Osama Abu Tabar, BSPharm, BCOP: Cancercare Pharmacist, Saudi Aramco Medical Services: Certified as BCOP.

 

 

 

The Immunology/Transplantation Practice and Research Network (PRN) has grown to almost 393 members. We encourage all members to get involved and to provide us with suggestions and comments to make our PRN even better.

Our PRN will be well represented at the American Transplant Congress 2013 Annual Meeting (the joint annual meeting of the American Society of Transplant Surgeons [ASTS] and the American Society of Transplantation [AST]), with many presentations involving PRN members (see below). Congratulations!

PROMOTIONS:

Timothy Clifford was promoted from a clinical specialist to a clinical pharmacy coordinator – transplantation at UK HealthCare.

Christopher Ensor changed institutions and started a new appointment: Assistant Professor, Pharmacy and Therapeutics, at the University of Pittsburgh School of Pharmacy.

Tiffany Kaiser was promoted to an associate professor of medicine, Division of Digestive Disease, University of Cincinnati.

Jennifer Trofe-Clark was promoted to an adjunct associate professor of medicine in the Renal Electrolyte and Hypertension Division of the Perelman School of Medicine, University of Pennsylvania. 

Gregory Smallwood was promoted to an associate professor of pharmacy practice, beginning July 1, 2013.

GRANTS:

Kathleen M. Tornatore has two active grants:

PUBLICATIONS

• We would like to congratulate the following PRN members on their publications during the past several months.
• Descourouez JL, Jorgenson MR, Wergin JE, Rose WE. Fosfomycin synergy in vitro with amoxicillin, daptomycin, and linezolid against vancomycin-resistant Enterococcus faecium from renal transplant patients with infected urinary stents. Antimicrob Agents Chemother 2013;57:1518-20.
• Gabardi S, Millen P, Hurwitz S, Martin ST, Roberts KL, Chandraker A. Atovaquone versus trimethoprim-sulfamethoxazole as Pneumocystis jiroveci pneumonia prophylaxis following renal transplantation. Clin Transplant 2012;26:E184-90.
• Hammond SP, Martin ST, Roberts KL, Gabardi S, Fuhlbrigge AL, Camp PC, Goldberg H, Marty FM, Baden LR. Cytomegalovirus in lung transplantation: impact of recipient seropositivity and duration of antiviral prophylaxis. Transpl Infect Dis 2012. [Epub ahead of print]
• Khanmoradi K, Knorr JP, Feyssa EL, Parsikia A, Jawa P, Dinh DB, Campos S, Zaki RF, Ortiz JA. Evaluating safety and efficacy of rabbit antithymocyte globulin induction in elderly kidney transplant recipients. Exp Clin Transplant. 2013 Feb 22. [Epub ahead of print]
•  Knorr JP, Javed I, Sahni N, Cankurtaran CZ, Ortiz JA. Metronidazole-induced encephalopathy in a patient with end-stage liver disease. Case Rep Hepatol 2012:DOI:10.1155/2012/209258.
•  Leeser DB, Aull MJ, Afaneh C, Dadhania D, Charlton M, Walker JK, Hartono C, Serur D, Del Pizzo JJ, Kapur S. Living donor kidney paired donation transplantation: experience as a founding member center of the National Kidney Registry. Clin Transplant 2012;26:E213-22.
• Martin ST, Torabi MJ, Gabardi S. Influenza in solid organ transplant recipients. Ann Pharmacother 2012;46:255-64.
• MacLaren R, Krisl JC, Cochrane RE, Mueller SW. A case-based approach to the practical application of dexmedetomidine in critically ill adults. Pharmacotherapy 2013;33:165-86. Muthukumar T, Afaneh C, Ding R, Tsapepas D, Lubetzky M, Jacobs S, Lee J, Sharma V, Lee J, Dadhania D, Hartono C, McDermott J, Aull M, Leeser D, Kapur S, Serur D, Suthanthiran M. HIV-infected kidney graft recipients managed with an early corticosteroid withdrawal protocol: clinical outcomes and messenger RNA profiles. Transplantation 2013;95:711-20.
• Shah S, Tsapepas DS, Kubin CJ, Martin ST, Mohan S, Ratner LE, Pereira M, Kapur S, Dadhania D, Walker-McDermott JK. Risk factors associated with Clostridium difficile infection after kidney and pancreas transplantation. Transplant Infect Dis. In press.
• Tiwari R, Tsapepas DS, Powell JT, Martin ST. Enhancements in healthcare information technology systems: customizing vendor supplied clinical decision support for a high-risk patient population. J Am Med Inform Assoc 2012. [Epub ahead of print]
•  Trofe-Clark J, Lemonovich TL; the AST Infectious Diseases Community of Practice. Interactions between anti-infective agents and immunosuppressants in solid organ transplantation. Am J Transplant 2013;13:318-26.
• Trofe-Clark J, Sparkes T, Gentile C, Van Deerline V, Sawinski D, Bloom RD. BK virus and genotype variance and discordant BK viremia PCR assay results [letter to the editor]. Am J Transplant. 2013 Feb .
•  Vu D, Tellez-Corrales E, Sakharkar P, Kissen MS, Shah T, Hutchinson I, Min DI. Genetic polymorphisms of NF-kB and allograft survival after kidney transplantation in the Hispanic allograft recipients. Transpl Immunol 2013;28:18-23.
•  Shah T, Vu D, Corrales-Tellez E, Cicciarelli J, Hutchinson I, Naraghi R, Min DI. Effects of mycophenolic acid on highly sensitized patients awaiting kidney transplant. Transpl Immunol 2013;28:32-7.
• Vu D, Sakharkar P, Tellez-Corrales E, Shah T, Hutchinson I, Min DI. Association of vitamin D binding protein polymorphism with long-term kidney allograft survival in Hispanic kidney transplant recipients. Mol Biol Rep 2013;40:933-9.
• Vu D, Tellez-Corrales E, Shah T, Naraghi R, Hutchinson IV, Min D. Association between granzyme B and perforin I polymorphisms and allograft outcomes in Hispanic kidney transplant recipients. Clin Transplant. In press.
• Vu D, Tellez-Corrales E, Shah T, Naraghi R, Hutchinson IV, Min D. Gene polymorphisms of UGT1A8, UGT1A9 and HNF-1α are associated with gastrointestinal symptoms in renal transplant recipients taking mycophenolic acid. Mol Biol Rep. In press.
• Wolf M, Descourouez JL, Hager DR, Djamali A. Peripheral administration of antithymocyte globulins: a review of current literature. Transplant Rev (Orlando) 2013;27:17-20.
• Staino C, Lewin JJ, Nesbit TW, Sullivan B, Ensor CR. Survey of transplant-related pharmacy services at large comprehensive transplant centers in the United States. Prog Transplant 2013;23:23-7.
• Ensor CR, Doligalski CT. Proliferation signal inhibitor toxicities after thoracic transplantation. Expert Opin Drug Metab Toxicol 2013;9:63-77.
• Cahoon WD, Ensor CR, Shullo MA. Alemtuzumab for cytolytic induction immunosuppression in cardiac transplantation. Prog Transplant 2012;22:344-50.
• Kruer R, Ensor CR. Colloids in the intensive care unit. Am J Health Syst Pharm 2012;69:1635-42.
• Hynicka LM, Ensor CR. Prophylaxis and treatment of respiratory syncytial virus in adult immunocompromised patients. Ann Pharmacother 2012;46:558-66.
• Jacobson PA, Schladt D, Israni A, Oetting WS, Lin Y, Leduc R, Guan W, Lamba V, Matas AJ; DeKAF Investigators. Genetic and clinical determinants of early, acute calcineurin inhibitor-related nephrotoxicity: results from a kidney transplant consortium. Transplantation 2012;93:624-31.
• Passey C, Birnbaum A, Brundage R, Oetting W, Leduc R, Israni A, Guan W, Matas A, Jacobson PA. Validation of tacrolimus equation to predict troughs using genetic and clinical factors. Pharmacogenomics 2012;13:1141-7.
• Abecassis M, Bridges ND, Clancy CJ, Dew MA, Eldadah B, Englesbe MJ, Flessner MF, Frank JC, Friedewald J, Gill J, Gries C, Halter JB, Hartmann EL, Hazzard WR, Horne FM, Hosenpud J, Jacobson P, Kasiske BL, Lake J, Loomba R, Malani PN, Moore TM, Murray A, Nguyen MH, Powe NR, Reese PP, Reynolds H, Samaniego MD, Schmader KE, Segev DL, Shah AS, Singer LG, Sosa JA, Stewart ZA, Tan JC, Williams WW, Zaas DW, High KP. Workshop Proceedings: Solid organ transplantation in older adults: current status and future research. Summarized the workshop held January 23–24, 2012. Am J Transplant 2012;12:2608-22.
• Jacobson PA, Schladt D, Oetting WS, Leduc R, Guan W, Matas AJ, Israni A; DeKAF Investigators. Lower calcineurin inhibitor doses in older compared to younger kidney transplant recipients yield similar troughs. Am J Transplant 2012;12:3326-36.
• Oetting WS, Guan W, Schladt DP, Leduc RE, Jacobson PA, Matas AJ, Chinnakotla S, Schröppel B, Murphy BT, Israni AK. Donor polymorphisms of TLR4 associated with graft failure in liver transplant recipients. Liver Transpl 2012;18:1399-405.
• Walsh KA, Lewis DA, Clifford TM, Hundley JC, Angulo P, Davis GA. Risk factors for venous thromboembolism in patients with chronic liver disease. Ann Pharmacother 2013;47:333-9.
• Thompson ML, Flynn JD, Clifford TM. Pharmacotherapy of lung transplantation: an overview. J Pharm Pract 2013;26:5-13.
• Schmidt N, Alloway RR, Walsh RC, Sadaka B, Shields AR, Girnita AL, Hanseman DJ, Woodle ES. Prospective evaluation of the toxicity profile of proteasome inhibitor-based therapy in renal transplant candidates and recipients. Transplantation 2012;94:352-61.
• Sadaka B, Alloway RR, Shields AR, Schmidt NM, Woodle ES. Proteasome inhibition for antibody-mediated rejection. Semin Hematol 2012;49:263-9.
• Kumar R, Pendyala P, Sudchada P, Venuto R, Gray V, Gundroo A, Attwood K, Wilding G, Tornatore K. Comparison of repeated measurement of clearance (CrCl) to estimated glomerular filtration rate (eGFR) in stable renal transplant recipients. J Nephrol. Published January 2013.
•  Tornatore KM, Minderman H, Chiang S, O’Loughlin K, Attwood K, Venuto RC. P-glycoprotein function in peripheral blood mononuclear cells in renal transplant recipients: sex and race influences. Presented at: Annual Meeting of Society of Clinical Pharmacology & Therapeutics; March 7 and 9, 2013; Indianapolis, IN.
• Meaney CJ, Brazeau D, Venuto RC, Chang S, Gundroo A, Leca N, Morse SE, Consiglio J, Cooper LM, Tornatore KM. Sex and haplotype associations with adverse effects of calcineurin inhibitors post-transplant. Poster presented at: Annual Meeting of Society of Clinical Pharmacology & Therapeutics; March 8, 2013; Indianapolis, IN.
•  Tornatore KM, Minderman H, O’Loughlin K, Attwood K, Venuto RC. Gender and race influences on P-glycoprotein function in peripheral blood mononuclear cells and relation to tacrolimus adverse effects post-transplant. Presented at: Annual Meeting of European Solid Organ Transplant/American Society of Transplantation; October 12, 2012; Nice, France.
• Tornatore KM, Minderman H, McGuire O, O’Loughlin K, Shan G, Wilding G, Venuto RC. Nuclear localization of nuclear factor of activated T-cells for tacrolimus immunosuppression post-transplantation. Presented at: Annual Meeting of European Solid Organ Transplant/American Society of Transplantation; October 12, 2012; Nice, France.

Books

Senior Editors: Brian K. Alldredge, Robin L. Corelli, Michael E. Ernst, B. Joseph Guglielmo, Pamala A. Jacobson, Wayne A. Kradjan, and Bradley R. Williams. Applied Therapeutics: The Clinical Use of Drugs, 10th ed. 2013. On bookshelves in summer 2013.

OTHER NOTABLE ACHIEVEMENTS

Knorr JP, Sjeime MT, Braitman L, Jawa P, Zaki RF, Ortiz JA. Concomitant use of proton pump inhibitors and mycophenolate mofetil is associated with an increased risk of rejection in kidney transplant recipients. Poster session presented at: American Society of Nephrology Kidney Week 2012; October 30 – November 4, 2012; San Diego, CA.

Jennifer K. McDermott (Walker). American Society of Transplantation, Hepatitis B Donor Consensus Conference; invited pharmacy COP representative.

Kathleen M. Tornatore is serving as an immunosuppressive clinical pharmacology fellowship mentor for Calvin Meaney from September 5, 2013, to September 5, 2014.

Tiffany Kaiser received The Ohio State University College of Pharmacy Josephine Sitterle Failer Alumni Award. The award recognizes an alumnus who has received a professional degree from the college of pharmacy within the past 10 years and has made an outstanding contribution(s) to community or professional service.

Accepted ATC 2013 Poster Presentations

• Trofe-Clark J, Sawinski D, Sparkes T, Goral S, Bleicher M, Bloom R. Single center experience with long-term prospective BK monitoring in renal transplantation.
• Stevens DR, Trofe-Clark J, Blumberg E, Wilck M, Weikert B, Goral S, Bleicher M, Sawinski D, Abt P, Levine M, Porrett P, Bloom RD. Increased risk of breakthrough infection among cytomegalovirus donor positive/recipient negative kidney transplant recipients receiving lower dose valganciclovir prophylaxis.
• Banff scoring in early and late acute cellular rejection predicts graft survival. Presenter: Jill Krisl, Transplant Pharmacy Fellow, University of Cincinnati.
• Phenotypic classification of acute rejection correlates with long-term graft survival. Presenter: Jill Krisl, Transplant Pharmacy Fellow, University of Cincinnati.
• A single center evaluation of intravenous immunoglobulin in renal transplantation. Presenter: Marissa L. Mako, PGY2 Pharmacy Resident-Solid Organ Transplantation, University of Wisconsin Hospital and Clinics.
• McDermott JK, Lee JR, Aull M, Muthukumar T, Hartono C, Serur D, Lee J, Sharma V, Kim J, Watkins A, Kapur S, Suthanthiran M, Dadhania D. Adjunctive bortezomib therapy for treatment of antibody mediated rejection in kidney transplant recipients.
• Jawa P, Knorr JP, Torres E, Raja R, Bradauskaite G, Kung SC. Donor hepatitis C status does not impact outcomes in hepatitis C positive kidney transplant recipients. Poster session to be presented at: 13th American Transplant Congress; May 18–22, 2013; Seattle, WA.
• Crowther B, Hall R, Arar M, Ranch D. BK polyoma virus infection and efficacy of leflunomide in pediatric renal transplant recipients. Poster session to be presented at: 13th American Transplant Congress; May 18–22, 2013; Seattle, WA.
• Kuten SA, Patel SR, Knight RJ, Gaber LW, Gaber AO. Course of BK virus infection in renal transplant recipients treated with cidofovir (oral presentation).
•  DeVos JM, Knight RJ, Patel SJ, Land G, Graviss E, Teeter L, Gaber AO. Independent risk factors for de novo DSA development through prospective monitoring (oral presentation).
• Patel SJ, DeVos JM, Knight RJ, Gaber AO. Are some “high-risk” renal transplant recipients higher risk than others?
• Patel SJ, Knight RJ, Moore LW, Lehnert AL, Agbetoba AA, DeVos JM, Gaber AO. Early experience with 3-month ciprofloxacin prophylaxis for BK infection in renal transplantation.
• Patel SJ, Knight RJ, Lawrecki TM, Masters BM, Tannous PY, Gaber AO. Comparison of creatinine reduction ratio on day 2 with 6-hour post-operative creatinine reduction in defining early renal allograft function.
• Patel SJ, DeVos JM, Dawson KL, Knight RJ, Gaber AO. Infectious complications after depleting or non-depleting antibody induction in kidney transplant recipients over 60 years of age.
• Ejaz NS, Alloway RR, Sadaka B, Shields AR, Abu Jawdeh A, Paterno F, Cardi M, Woodle ES. Proteasome inhibitor-related toxicities in a prospective trial of desensitization. Poster session to be presented at: 13th American Transplant Congress; May 18–22, 2013; Seattle, WA.
• Min D, Vu D, Kawawet B, Poulsen J, Hutchinson I, Naraghi R, Shah T. Effect of ciprofloxacin on BK virus infection after renal transplantation. Poster session to be presented at: 13th American Transplant Congress; May 18–22, 2013; Seattle, WA.

Accepted ATC 2013 Oral Presentations

• Descourouez J, Hager D, Leverson G, Hofmann RM, Djamali A, Bellingham J, Odorico J, Sollinger H, Pirsch J. Incidence, risk factors and outcomes of BK viremia and nephropathy following kidney, simultaneous kidney-pancreas or pancreas after kidney transplant. Oral presentation session to be presented at: 13th American Transplant Congress; May 18–22, 2013; Seattle, WA.
• Mako ML. Thymoglobulin is associated with a significant reduction in de novo donor-specific antibodies and antibody mediated rejection in moderately sensitized renal transplant recipients. Oral presentation session to be presented at: 13th American Transplant Congress; May 18–22, 2013; Seattle, WA.
• DeVos JM, Knight RJ, Patel SJ, Land GA, Graviss E, Teeter L, Gaber AO. Identification of independent risk factors for de novo DSA development through prospective monitoring. Oral presentation session to be presented at: 13th American Transplant Congress; May 18–22, 2013; Seattle, WA.
• Jantz AS, Patel SJ, Moore LW, Knight RJ, Gaber AO. Application of rejection reversal as defined by efficacy endpoints in present day renal transplantation.
• Jantz AS, Patel SJ, Moore LW, Gaber LW, Knight RJ, Gaber AO. Creatinine as a marker of rejection reversal in recipients with post-treatment biopsies.
• Ejaz NS, Shields AR, Alloway RR, Sadaka B, Girnita A, Mogilishetty G, Kremer J, Cardi M, Woodle ES. A prospective, randomized, pilot study of B-cell targeted induction therapy in sensitized kidney transplant recipients: final report. Oral presentation session to be presented at: 13th American Transplant Congress; May 18–22, 2013; Seattle, WA.
• Wang U, Yang A, Dong M, Busque S. Safety and effectiveness of valganciclovir for cytomegalovirus prophylaxis in solid organ transplant patients on hemodialysis.

 

Grants (limited to 3)

Melody Berg received part of a CDC grant to develop the Regional Tuberculosis Consultation and Education Center at Mayo Clinic and received funding to be the pharmacist faculty member on the multidisciplinary team.

Kerry LaPlante received a $705,000 grant (as Principal Investigator) from Pfizer Pharmaceuticals (ASPIIRE grant) titled “Addressing Educational and Coordination Barriers for Adult Pneumococcal Disease Prevention in Rhode Island.” She also received a second ($50,000) grant from Pfizer Pharmaceuticals (ASPIIRE grant) titled “Burden of Pneumococcal Disease in a National Cohort of Adults 50 Years and Older: Focus on Incidence and Prevalence of Disease Comorbidities.” Finally, she received a $100,000 grant from Pfizer Pharmaceuticals (ASPIIRE grant) titled “The Effects of Obesity on the Comparative Effectiveness of Linezolid and Vancomycin in Methicillin-Resistant Staphylococcus aureus Pneumonia.”

Publications (limited to 3)

Dumond J, Adams J, Prince H, Kendrick R, Wang R, Jennings S, Malone S, White N, Sykes C, Corbett A, Patterson K, Forrest A, Kashuba A. Pharmacokinetics of two common antiretroviral regimens in older HIV-infected patients: a pilot study. HIV Med. 2013 Feb 24. [Epub ahead of print]

Adams JL, Sykes C, Menezes P, Prince HMA, Patterson KB, Fransen K, Crucitti T, De Baetselier I, Van Damme L,

Kashuba ADM. Tenofovir diphosphate and emtricitabine phosphate concentrations in blood cells compared with isolated peripheral blood mononuclear cells: a new measure of antiretroviral adherence? J Aquir Immune Defic Syndr 2013;62:260-6.

Adams JL, Greener B, Kashuba ADM. Pharmacology of HIV integrase inhibitors. Curr Opin HIV AIDS 2012;7:390-400.

Nicol MR, Adams JL, Kashuba ADM. HIV PrEP trials: the road to success. Clin Invest. 2013 March. [Epub ahead of print]

Shibata A, McMullen E, Pham A, Belshan MA, Sanford B, Zhao Y, Goede M, Date A, Destache CJ. Polymeric nanoparticles containing combination antiretroviral drugs for HIV-1 treatment. AIDS Rev Hum Retrovir. 2013 Jan 7. [Epub ahead of print]

Date AA, Shibata A, Goede M, Sanford B, La Bruzzo K, Belshan M, Destache CJ. Development and evaluation of a thermosensitive vaginal gel containing raltegravir + efavirenz loaded nanoparticles for HIV prophylaxis. Antivir Res. 2012. [Epub ahead of print]

Knaak E, Cavalieri SM, Elsasser GN, Gonitzke A, Preheim LC, Destache CJ. Does antibiotic de-escalation for nosocomial pneumonia impact intensive care unit length of stay? Infect Dis Clin Pract 2012.

Sussman R, Farkas A, Lee A, Evaluation of pharmacist managed vancomycin therapy compared to physician managed dosing in establishing timely and therapeutic vancomycin serum concentrations at a community hospital. Paper presented at: Annual Meeting of the American College of Clinical Pharmacy; October 21–24, 2012; Hollywood, FL.

Farkas A. Pharmacodynamic profiling of prolonged infusion of ertapenem in critically ill patients with early-onset ventilator-associated pneumonia through the use of a population pharmacokinetic model and Monte Carlo simulation. Accepted for presentation at: 23rd European Congress of Clinical Microbiology and Infectious Diseases; April 27–30, 2013; Berlin, Germany.

Farkas A. Model-based optimization of daptomycin dosing during high-intensity renal replacement therapy. Accepted for presentation at: 23rd European Congress of Clinical Microbiology and Infectious Diseases; April 27–30, 2013; Berlin, Germany.

Santayana E, Grim SA, Janda WM, Layden JE, Lee TA, Clark NM. Risk factors and outcomes associated with vancomycin-resistant Enterococcus (VRE) infections with reduced susceptibility to linezolid. Diagn Microbiol Infect Dis 2012;74:39-42.

Hirsch EB, Guo B, Chang KT, Cao H, Ledesma KR, Singh M, Tam VH. Assessment of antimicrobial combinations for KPC-producing Klebsiella pneumoniae. J Infect Dis 2013;207:786-93.

Rose L. Management of HIV/AIDS in Older Adults. Omnicare Geriatric Pharmaceutical Care Guidelines® [Internet]; Updated 2013 Jan.

Segarra-Newnham M, Church TJ. Pharmacotherapy for methicillin-resistant Staphylococcus aureus nosocomial pneumonia. Ann Pharmacother 2012;46:1678-87.

Segarra-Newnham M, Coakley C. Salvage options for eradication of Helicobacter pylori during tetracycline backorder. J Pharm Technol 2012;28:187-92.

Other Notable Achievements

Mary Beth Brinkman, Lindsey Childs, Tom Dilworth, Ifeanyi Onor, and Kyle Sobecki became Board Certified Pharmacotherapy Specialists in December 2012.

Lindsey Childs was appointed to the ASHP New Practitioners Forum Executive Committee (June 2013 – May 2014).

Tom Dilworth and Lucia Rose received AAHIVP credentialing.

Andras Farkas became a member of the International Society of Anti-Infective Pharmacology’s group for bedside ICU antibiotic dosing, a working group that focuses on developing software applications to facilitate antibiotic dosing for critically ill patients at the bedside.

 

During its annual business meeting and networking forum (October 2012), the Nephrology PRN discussed plans for the PRN. Several students attended and participated in the discussion. Travel award winner Desiree Kosmisky, a pharmacy student from the University of Pittsburgh School of Pharmacy, provided an interesting presentation of a project titled “Student Pharmacist–Based Medication Reconciliation to Identify Drug Record Discrepancies and Medication-Related Problems in an Outpatient Hemodialysis Unit,” which was followed by an active discussion session. The Nephrology PRN was well represented at the 2012 American Society of Nephrology Renal Week meeting, with several members involved with committees, providing invited presentations and poster presentations. The PRN will also be well represented at the spring 2013 National Kidney Foundation Meeting, with several members involved in symposium planning, as invited speakers, and in committees and poster presentations.

Grants/Research

Amy Barton Pai. Contract: A Phase 1, Single-Center, Open-Label, Single-Dose Study to Assess the Pharmacokinetics of Ceftaroline Fosamil in Adults Receiving Continuous Renal Replacement Therapy. Forest Research Institute.

Publications

• Hogan J, Schwenk MH, Radhakrishnan J. Should mycophenolate mofetil replace cyclophosphamide as first-line therapy for severe lupus nephritis? Kidney Int 2012;82:1256-60.
• Low CL. Sodium citrate 4% versus heparin as a lock solution in hemodialysis patients with central venous catheters. Am J Health Syst Pharm 2013;70:131-6.
• Rifkin DE, Abdelmalek JA, Miracle CM, Low C, Barsotti R, Rios P, Stepnowsky C, Agha Z. Linking clinic and home: a randomized, controlled clinical effectiveness trial of real-time, wireless blood pressure monitoring for older patients with kidney disease and hypertension. Blood Press Monit 2013;18:8-15.
• Golightly LK, Teitelbaum I, Kiser TH, Levin DA, Barber GR, Jones MA, Stolpman NM, Lundin KS. Renal Pharmacotherapy: Dosage Adjustment of Medications Eliminated by the Kidneys. New York: Springer Science+Business Media, 2013:1-752. Available at www.springer.com/medicine/nephrology/book/978-1-4614-5799-2. 
• Jin R, Cai L, Tan M, McHutchison JG, Dowling TC, Howell CD. Optimum ribavirin exposure overcomes racial disparity in efficacy of peginterferon and ribavirin treatment for hepatitis C genotype 1. Am J Gastroenterol 2012;107:1675-83.
• Jin R, Fossler MJ, McHutchison JG, Howell CD, Dowling TC. Population pharmacokinetics and pharmacodynamics of ribavirin in patients with chronic hepatitis C genotype 1 infection. AAPS J 2012;14:571-80.
• Connelly K, Nguyen TV. Human immunodeficiency virus-associated nephropathy: a case assessment. J Nurse Pract 2013;9:40-5.
• Editor – Nguyen TV, et al. NJPhA Student Practitioner Newsletter. Published by NJPhA. Available at www.njpharmacist.org. 2012 fall (October).
• Mateo-Carrasco H, Gálvez-Contreras MC, Fernández-Ginés FD, Nguyen TV. Elevated liver enzymes resulting from an interaction between raltegravir and panax ginseng: a case report and brief review. Drug Metab Drug Interact 2012;27:171-5.
• Mueller BA, Scoville BA. Adding to the armamentarium: antibiotic dosing in extended dialysis. Clin J Am Soc Nephrol 2012;7:373-5.
• Eyler RF, Klein KC, Mueller BA. The pharmacokinetics of oseltamivir and oseltamivir carboxylate in a critically ill pediatric patient receiving extracorporeal membrane oxygenation and continuous venovenous hemodialysis. J Pediatr Pharmacol Ther 2012;17:173-6.
• Eyler RF, Heung M, Pleva M, Sowinski KM, Park PK, Napolitano LM, Mueller BA. The Pharmacokinetics of Oseltamivir and Oseltamivir Carboxylate in Critically Ill Subjects Receiving CVVHD and/or ECMO. Pharmacotherapy 2012;32:1061-9.
• Butterfield JM, Mueller BA, Patel N, Cardone KE, Grabe DW, Salama NN, Lodise TP. Daptomycin pharmacokinetics and pharmacodynamics in a pooled sample of patients receiving thrice-weekly hemodialysis. Antimicrob Agents Chemother 2013;57:864-72.
• Scoville BA, Mueller BA. Medication dosing in critically ill patients with acute kidney injury treated with renal replacement therapy. Am J Kidney Dis. 2012 Nov 2. [Epub ahead of print]
• Scoville BA, Heung M, Mueller BA. Hemofiltration circuit use beyond 72 hours in pediatric continuous renal replacement therapy. Int J Artif Organs 2012;35:1025. 
• Vilay AM, Mueller BA. Intradialytic oral nutritional supplements improve quality of life [letter]. Am J Kidney Dis 2013;61:349.
• Mueller BA, Jasiak KD, Thiel SR, Stevenson JM, Vilay AM, Scoville BA, Churchwell MD, Pasko DA, Perkins N. Vibration enhances clearance of solutes with varying molecular weights during in vitro hemodialysis. ASAIO J 2013;59:140-4.
• Foote E, Szarek J, Arscott K, Brady J, Clarke V, Easton D, Farrell M, Goss S, Walline V, Waters S. A Large Scale, Collaborative Care Summit to Promote Interprofessional Learning: Ischemic Stroke. MedEdPORTAL 2013. Available at www.mededportal.org/publication/9306.
• El Nekidy WS, El-Masri MM, Umstead GS, Dehoorne-Smith M. Factors influencing vancomycin loading dose for hospitalized hemodialysis patients: prospective observational cohort study. Can J Hosp Pharm 2012;65:436-42.
• Yaseen O, El Nekidy WS, Ibrahim AR, Jasey BB, Guignard M, Kadri A. Cyclic pseudoperitonitis secondary to endometriosis in a peritoneal dialysis patient. Perit Dial Int 2012;32:662-4.
• Yaseen O, El-Masri MM, El Nekidy WS, Soong D, Ibrahim M, Speirs JW, Kadri A. Comparison of alteplase (tissue plasminogen activator) high-dose vs. low-dose protocol in restoring hemodialysis catheter function: the ALTE-DOSE study. Hemodial Int. 2012 Nov 26. [Epub ahead of print]
• Dowling TC, Rodriguez de Bittner M, Perez Z, Briglia A, Peralta L. Evaluation of drug metabolism in Hispanic Americans with type 2 diabetes. J Diabetes Res Clin Metab 2012 (doi: http://dx.doi.org/10.7243/2050-0866-1-22).
• Pai AB, Patel H, Prokopienko A, Gertzberg N, Alsaffar H, Neumann P, Punjabi A, Johnson A. Lipoteichoic acid from Staphylococcus aureus induces lung endothelial cell barrier dysfunction: role of reactive oxygen and nitrogen species. PLoS One 2012;7. [Epub ahead of print]
• Asif A, Carrillo R, Garisto JD, Monrroy M, Khan RA, Castro H, Merrill D, Ali AS, Pai AB, Waldman J, Salman L. Prevalence of chronic kidney disease in patients undergoing cardiac rhythm device removal. Semin Dial. 2012 Jul 11. 
• Conner TA, McQuade CR, Olp J, Pai AB. Effect of intravenous vitamin C on reactive oxygen species generation, cytokine activation and oxidative stress in hemodialysis (HD) patients receiving intravenous iron sucrose (IS). Biometals. 2012 Jun 17.
• Pai AB, Garba AO. Ferumoxytol: a silver lining in the treatment of anemia of chronic kidney disease: or another dark cloud? J Blood Med 2012;3:77-85.
• Kubotera N, Prokopienko A, Garba AO, Pai AB. Endotoxin binding by sevelamer: potential impact on nutritional status. Int J Nephrol. Accepted for publication.
• Richardson MM, Nolin TD. A decade after the KDOQI CKD guidelines: impact on medication safety. Am J Kidney Dis 2012;60:713-5.
• Cardone KE, Grabe DW, Kulawy RW, Daoui R, Roglieri J, Meola S, Drusano GL, Lodise TP. Ertapenem pharmacokinetics and pharmacodynamics during continuous ambulatory peritoneal dialysis. Antimicrob Agents Chemother 2012;56:725-30.
• Vilay AM, Wong CS, Schrader RM, Mercier RC, Seifert SA. Indicators for serious kidney complications associated with toxic exposures: an analysis of the National Poison Data System. Clin Toxicol (Phila) 2013;51:96-105.
• Churchwell MD. Use of an in vitro model of renal replacement therapy systems to estimate extracorporeal drug removal. J Clin Pharmacol 2012;52(1 suppl):35S-44S.
• Samtani MN, Vaccaro N, Cirillo I, Matzke GR, Redman R, Nandy P. Doripenem dosing recommendations for critically ill patients receiving continuous renal replacement therapy. ISRN Pharmacol 2012;2012:782656.
• American College of Clinical Pharmacy; Kirwin J, Canales AE, Bentley ML, Bungay K, Chan T, Dobson E, Holder RM, Johnson D, Lilliston A, Mohammad RA, Spinler SA. Process indicators of quality clinical pharmacy services during transitions of care. Pharmacotherapy 2012;32:e338-47. 

BCPS Certification 2012

Ifeanyi Onor, Pharm.D., B.S., BCPS; clinical assistant professor and adult medicine clinical pharmacist; College of Pharmacy – Division of Clinical and Administrative Sciences; Xavier University of Louisiana

BCAP Certification 2012

Wasim S. El Nekidy, Pharm.D., BSPharm, BCPS, BCACP, Clinical Pharmacy Specialist – Department of Nephrology, Hotel-Dieu Grace Hospital, Windsor, Ontario, Canada

Commission for Certification in Geriatric Pharmacy (CCGP)

Leslie Richard, Pharm.D., CGP, Cary, North Carolina

Symposium Presentations

American Society of Nephrology Annual Meeting

Amy Barton Pai. Role of pharmaceutical care on drug use and hospitalizations in ESRD patients. Paper presented at: American Society of Nephrology, Renal Week; November 2, 2012; San Diego, CA.

Michael Schwenk. Update: Treatment of Severe Lupus Nephritis Annual Regional Symposium on Chronic Kidney Disease. Featuring: CKD: The Cardiac-Kidney-Diabetes Connection. The National Kidney Foundation Serving Greater New York.

 

The Pain and Palliative Care PRN members continue to receive recognition for their accomplishments in publications, promotions, and other areas of achievement.

 Awards

• Alvarez NA. Jack R. Cole, Ph.D, Distinguished Alumnus Award, The University of Arizona College of Pharmacy, 2012.
• Alvarez NA. Stellar Award – Clinical Development and Medical Science Department, Endo Health Solutions, Fourth quarter 2012.
• Alvarez NA.  Leadership Attribute Award – Collaboration, Endo Health Solutions, Fourth quarter 2012.
• McPherson ML. Presidential Citation; Hospice and Palliative Care Nurses Association; February 2013.
• McPherson ML. University of Maryland Baltimore Founder’s Week; Campus Teacher of the Year; October 2012.

 Grants

• Department of Health and Mental Hygiene, State of Maryland, 2013. “Controlled Dangerous Substance Emergency Preparedness Plan.” $600,970; Walker K, McPherson ML, Co-Principal Investigators.
• NIH Pain Consortium: “Center of Excellence in Pain Education (CoEPE University of Maryland).” $325,000; McPherson ML, Gordon S, Co-Principal Investigators.

 Publications

• Sasu-Tenkoramaa J, Fudin J. Neuropathy in the cancer patient: causes and cures. Pract Pain Manage 2013;13:53-67.
• Kubotera N, Fudin J. Pain management for pharmacists – concepts and definitions. CE program of the University of Connecticut School of Pharmacy and Drug Topics. Drug Top 2013;April:52-61. In print.
• Fudin J, Fontenelle DV, Payne A. Rifampin reduces oral morphine absorption; a case of transdermal buprenorphine selection based on morphine pharmacokinetics. J Pain Palliat Care Pharmacother 2012;26:362-7.
• Fudin J. Commentary. PROMPT Challenges PROP’s Petition. October 2012. Pract Pain Manage 2012;12:12-4.
• Haroutiunian S, McNicol ED, Lipman AG. Methadone for chronic non-cancer pain in adults. Cochrane Database Syst Rev 2012;11:CD008025.
• Liu J, Wang LN, McNicol ED. Pharmacological treatment for pain in Guillain-Barré syndrome [protocol]. Cochrane Database Syst Rev 2012;7:CD009950.
• McPherson ML. Opioid therapy for cancer pain. In: Tracey I, ed. Pain 2012 Refresher Courses, 14th World Congress on Pain: International Association for the Study of Pain. Seattle: IASP Press, 2012.
• McPherson ML, Kim M, Walker KA. 50 practical medication tips at end of life. J Support Oncol 2012;10:222-9.
• Sera LC, McPherson ML. Pharmacokinetics and pharmacodynamics changes associated with aging and implications for drug therapy. Clin Geriatr Med 2012;28:273-86.

 Other Notable Achievements

• Alvarez NA. Installed as Trustee-at-Large – American Pharmacists Association – Second term.
• Alvarez NA. Established an APhA Academy of Student Pharmacists scholarship through the APhA Foundation – First awarded 2013.
• Alvarez NA.  Leadership Weekend – California Pharmacists Association – Programming Codirector/Presenter, November 2012.
• Fudin J. Established new PGY2 Pain Residency Program at Stratton VA in Albany, NY (Candidate Status).
• Fudin J. Selected as ACCP National Mentor for residents, fellows, and graduate students.
• Fudin J. Founder of PROMPT (Professionals for Rational Opioid Monitoring and Pharmacotherapy).
• McNicol ED. Developed “blended learning” model for master’s degree in pain research, education and policy: http://publichealth.tufts.edu/Academics/MS-Pain-Research-Education-and-Policy/Programs-of-Study/MS-Pain-Research-Education-and-Policy.

Chair:   Hanna Phan, Pharm.D., BCPS
Immediate Past Chair:  Kelly Bobo, Pharm.D., BCPS
Chair-Elect:  Barnabas John, Pharm.D., BPCS
Secretary:  Audrey Kennedy, Pharm.D., BCPS
The Pediatrics PRN is pleased to report the activities of its committees and to recognize the following accomplishments of its members.

Recent PRN Activity

Collaboration Committee (Chair: Joseph LaRochelle) – The efforts of the committee (which was led by Richard Parrish for this initial manuscript) have resulted in a dual publication in Pharmacotherapy and Journal of Pediatric Pharmacology and Therapeutics (see listing below). The collaboration committee has been hard at work designing a second paper that will focus on the clinical specialist’s role in the care of pediatric patients. This 18-person team has divided the main sections of the paper and is in the process of writing them. We have designed in the plan an editorial phase, which will include people with expertise in editing. After the editing phase, we will add the final touches to the paper and prepare for the final version. We have included an internal peer-review process that will provide comments to be addressed in the paper before submission to the journal.

Education Committee (Chair: Kelly Bobo) – The Education Committee continues to work on developing and submitting session proposals for the ACCP Annual Meeting each year.

Nominations Committee (Chair: Tracy Hagemann) – Continuing to encourage membership nominations for recognition within ACCP and candidates for office starting fall 2013. This year, we will be electing a new chair-elect (2-year term) and secretary (2-year term).

Student and Resident Committee (Chair: Chasity Shelton) – This is a new committee formed as part of the initiative to increase student and resident interest in pediatrics and participation in the Pediatrics PRN. Programs are currently being developed to provide mentorship and networking opportunities for students and residents.

Travel Award Committee (Chair: Hanna Phan) – Two awards will be available for application for 2013. These awards are for resident and student pediatric PRN members who are presenting (e.g., poster) at the ACCP Annual Meeting. Recipients of the award will be recognized at the annual PRN business meeting and will present their projects to those in attendance.

Promotions

Varsha Bhatt-Mehta was promoted to clinical professor of pharmacy, Department of Clinical Sciences, College of Pharmacy, University of Michigan.

Bernard Lee was promoted to pediatric clinical pharmacy manager at University of North Carolina Hospitals.

Grants

Deborah Raithel received the Pediatric Pharmacy Advocacy Group (PPAG) Neonatal Pharmacy Resident Small Research Grant for the project titled, “Neonatal Indomethacin for Prevention of Intraventricular Hemorrhage: A Study of Plasma Concentrations, Pharmacogenomic Factors, and Outcomes.”

Rebecca Chhim received one of the 2012–2013 American Association of Colleges of Pharmacy (AACP) New Investigator Awards for the project titled “Ethanol Dose Escalation Safety Study in Neonates and Infants.”

Awards

Milap Nahata was named a recipient of the 2013 recipient of the Sumner J. Yaffe Lifetime Achievement Award in Pediatric Pharmacology and Therapeutics from the Pediatric Pharmacy Advocacy Group. He will deliver the Yaffe Award Lecture during the 22nd Annual PPAG Meeting and 2013 Pediatric Pharmacy Conference on May 3, 2013.

Robert Kuhn was named the Kentucky Hospital Association Professor, an endowed professorship supported by the Kentucky Hospital Association.

Publications

• Bhatt-Mehta V, Buck ML, Chung AM, Farrington EA, Hagemann TM, Hoff DS, La Rochelle JM, Pettit RS, Phan H, Potts AL, Smith KP, Parrish RH II. Recommendations for Meeting the Pediatric Patient’s Need for a Clinical Pharmacist: A Joint Opinion of the Pediatrics Practice and Research Network of the American College of Clinical Pharmacy and the Pediatric Pharmacy Advocacy Group.
  • J Pediatr Pharmacol Ther 2012;17:281-91.
  • Pharmacotherapy 2013;33:243-51.

• Pediatric Pharmacotherapy. Lenexa, KS: American College of Clinical Pharmacy, 2012. ISBN: 978-1-932658-89-7.
  • Editorial board: Sandra Benavides, Milap C. Nahata, Michael Chicella, Michelle Condren, Lea S. Eiland, Tracy M. Hagemann, Jennifer Le, Kalen Manasco, Brady S. Moffett, Heather L. VandenBussche
  • Contributing authors: Susan M. Abdel-Rahman, Sandra Benavides, Varsha Bhatt-Mehta, Jacob T. Brown, Michael Chicella, Joshua Caballero, Jennifer W. Chow, Michelle Condren, Catherine M. Crill, Kimberley Le Dinh, Lea S. Eiland, Tiffany-Jade M. Kreys, Tracy M. Hagemann, Kristin C. Klein, Robert J. Kuhn, Mark Haase, Cherry W. Jackson, Weng Man Lam, Jennifer Le, Raymond A. Lorenz, Lisa Lubsch, Kalen Manasco, Erin J. McDade, Jaime Miller, Brady S. Moffett, Milap C. Nahata, Johanna L. Norman, Vinita B. Pai, Hanna Phan, Christina C. Piro, Amy L. Potts, Jose A. Rey, Juan Carlos Rodriguez, Jason B. Sauberan, Christopher A. Thomas, Heather L. VandenBussche, Jeffrey L. Wagner, Mary A. Worthington, Grace Lee, Stephanie D. Natale, Teresa V. Lewis, Heidi Trinkman, Alix A. Dabb, M. Brooke Bernhardt, Peter N. Johnson

• Polischuk E, Vetterly CG, Crowley KL, et al. Implementation of a standardized process for ordering and dispensing of high-alert emergency medication infusions. J Pediatr Pharmacol Ther 2012;17:166-72.
• Hiteshew KJ, Franz T, Lamberjack K, Chen AMH. Don’t leave without them: dispensing asthma medications to pediatric patients upon discharge is associated with decreased hospital readmissions. Innov Pharm 2012;3:Article 2.
• LaRochelle JM, Ghaly M, Creel AM. Clinical pharmacy faculty interventions in a pediatric intensive care unit: an eight-month review. J Pediatr Pharmacol Ther 2012;17:263-9.
• Manji A, Beyene J, Dupuis LL, Phillips R, Lehrnbecher T, Sung L. Outpatient and oral antibiotic management of low-risk febrile neutropenia are effective and safe in children – a systematic review of prospective trials. Support Care Cancer 2012;20:1135-45.
• Manji A, Lehrnbecher T, Dupuis LL, Beyene J, Sung L. A meta-analysis of anti-pseudomonal penicillins and cephalosporins in pediatric patients with febrile neutropenia. Pediatr Infect Dis J 2012;31:353-9.
• Sung L, Manji A, Beyene J, Dupuis LL, Alexander S, Phillips R, Lehrnbecher T. Fluoroquinolones in children with fever and neutropenia. Pediatr Infect Dis J 2012;31:431-5.
• Manji A, Lehrnbecher T, Dupuis LL, Beyene J, Sung L. A systematic review and meta-analysis of anti-pseudomonal penicillins and carbapenems in pediatric febrile neutropenia. Support Care Cancer 2012;20:2295-304.
• Dupuis LL, Ethier MC, Tomlinson D, Hesser T, Sung L. A systematic review of symptom assessment scales in children with cancer. BMC Cancer 2012;12:430.
• Schechter-Finkelstein T, Avila L, Frangoul H, Domm J, Dupuis LL, Naitani R, Pollock-Barziv S, Roifman C, Gassas A, Doyle J. The effect of acute graft versus host disease on the outcome of second allogeneic hematopoietic stem cell transplant in children. Leuk Lymphoma 2013;54:105-9.
• Lehrnbecher T, Phillips R, Alexander S, Alvaro F, Carlesse F, Fisher B, Hakim H, Santolaya M, Castagnola E, Davis BL, Dupuis LL, Gibson F, Groll AH, Gaur A, Gupta A, Kebudi R, Petrilli A, Steinbach WJ, Villarroel M, Zaoutis T, Sung L. Guideline for the management of fever and neutropenia in children with cancer and/or undergoing hematopoietic stem cell transplantation. J Clin Oncol 2012;30:4427-38.
• Dupuis LL, Seto W, Teuffel O, Gibson P, Schultz K, Doyle J, Gassas A, Egeler RM, Sung L, Schechter T. Prediction of area under the cyclosporine concentration vs time curve in children undergoing hematopoietic stem cell transplant. Biol Blood Marrow Transplant 2013;19:418-23.
• Dupuis LL, Boodhan S, Holdsworth M, Robinson PD, Hain R, Portwine C, O’Shaughnessy E, Sung L. Guideline for the Prevention of Acute Nausea and Vomiting Due to Antineoplastic Medication in Pediatric Cancer Patients. Pediatric Oncology Group of Ontario; August 2012. Available at www.pogo.ca/healthcare/practiceguidelines/acuteainvguideline/.
• Gargasz A. Neonatal and pediatric parenteral nutrition. AACN Adv Crit Care 2012;23:451-64.
• Dembinski K, Gargasz AE, Dabrow S, Rodriguez L. Three distinct cases of copper deficiency in hospitalized pediatric patients. Clin Pediatr (Phila) 2012;51:759-62.
• Walker MC, Lam WM, Manasco KB. Review of continuous and extended infusions of beta-lactam antibiotics in the pediatric population. Ann Pharmacother 2012;46:1537-46.
• Manasco KB, Bradley AM, Gomez TA. Survey of learning opportunities in academia for pharmacy residents. Am J Health Syst Pharm 2012;69:1410-4.
• Sullins AK, Richard AA, Manasco KB, Phillips MS, Gomez TA. Which comes first, CPOE or eMAR? A retrospective analysis of health information technology implementation. Hosp Pharm 2012;47:1-8.
• Patanwala AE, Christich AC, Jasiak KD, Edwards CJ, Phan H, Snyder EM. Age-related Differences in Propofol Dosing for Procedural Sedation in the Emergency Department. J Emerg Med. 2013 Jan 16. [Epub ahead of print]
• Phan H, Porter K, Nahata M. Prescribing trends for medications in the treatment of adolescents and young adults with type 2 diabetes mellitus. J Manage Care Pharm 2012;18:607-14.
• Jasiak KD, Phan H, Christich AC, Edwards CJ, Skrepnek GH, Patanwala AE. Induction dose of propofol for pediatric patients undergoing procedural sedation in the emergency department. Pediatr Emerg Care 2012;28:440-2.
• Whittington Goldstone L, Kennedy AK, Clark JS, Phan H. Developing and evaluating clinical pharmacy services. In: Chisholm-Burns MA, Vaillancourt AM, Shepherd M, eds. Pharmacy Management, Leadership, Marketing, and Finance, 2nd ed. Burlington, MA: Jones & Bartlett, 2012:199-215.
• Chhim RF, Shelton CM, Christensen ML. Recent new drug approvals – part 2: drugs undergoing active clinical studies in children. J Pediatr Pharmacol Ther 2013;18:14-38.
• Shelton CM, Chhim RF, Christensen ML. Recent new drug approvals – part 1: drugs with pediatric indications. J Pediatr Pharmacol Ther 2012;17:329-39.
• Karimi Khaledi M, Suda KJ, Shelton CM. Tardive dyskinesia after short-term treatment with oral metoclopramide in an adolescent. Int J Clin Pharm 2012;34:822-4.
• Hicks JK, Shelton CM, Sahni JK, Christensen ML. A retrospective evaluation of enoxaparin dosing in patients 48 weeks postmenstrual age or younger located in a neonatal intensive care unit. Ann Pharmacother 2012;46:943-51. 

Other Notable Achievements

A Pediatric Special Interest Group within the American Association of Colleges of Pharmacy was approved and formed. Kalen B. Porter (Chair), Tracey Hagemann (Chair-Elect), and Hanna Phan (Secretary) will serve in office starting in the summer of 2013.

 

Promotion

Rick Barbarash, Pharm.D., FCCP, AstraZeneca, LP, Medical Affairs and Strategic Development. Promoted from senior regional scientific manager to executive regional scientific manager

Activities
The Industry PRN surveyed the members to assess whether there was a need to change the name of the PRN.

 

The PK/PD/PG PRN has been busy organizing a focus session for the upcoming ACCP Annual Meeting in October 2013. We look forward to an exciting session on applications of pharmacogenomics in clinical practice.

Publications

Formea CM, Nicholson WT, McCullough KB, Berg KD, Berg ML, Cunningham JL, Merten JA, Ou NN, Stollings JL. Development and evaluation of a pharmacogenomics educational program for pharmacists. Am J Pharm Educ 2013;77:Article 9.

Murphy JE, Lee M, eds. Cardiology/endocrinology. Pharmacotherapy Self-Assessment Program, 8th ed. Lenexa, KS: American College of Clinical Pharmacy, 2013.

 

The Women’s Health PRN members continue to receive recognition for their accomplishments in publications, promotions, and other areas of achievement.

Publications

• Forinash AB, Yancey AM. Osteoporosis. In: Murphy J, Lee M, eds. Pharmacotherapy Self-Assessment Program, 2013 Book 1. Cardiology and Endocrinology. Lenexa, KS: American College of Clinical Pharmacy, 2013:51-77.
• Forinash AB, Yancey AM, Barnes KN, Myles T. The use of galactogogues in the breastfeeding mother. Ann Pharmacother 2012;46:1392-404.
• Painter N, Morello C, Singh R, McBane S. An evidence-based and practical approach to using Bydureon in patients with type 2 diabetes. J Am Board Fam Med 2013;26:203-10.

• McBane S. Tobacco cessation strategies. In: Dong B, Elliott D, eds. Ambulatory Care Self-Assessment Program, 2013 Book 1. Pulmonary and Preventive Care. Lenexa, KS: American College of Clinical Pharmacy, 2013:104-18.
• McClendon KS. Phentermine/topiramate ER (Qsymia): second new obesity medication approved in 2012 [update]. In: Talbert RL, DiPiro JT, Matzke GR, Posey LM, Wells BG, Yee GC, eds. Pharmacotherapy: A Pathophysiologic Approach, 8th ed. New York: McGraw-Hill, 2012. Available at www.accesspharmacy.com/updatesContent.aspx?aid=4000240. Accessed December 3, 2012.
• McClendon KS. Lorcaserin approved for treatment of obesity [update]. In: Talbert RL, DiPiro JT, Matzke GR, Posey LM, Wells BG, Yee GC, eds. Pharmacotherapy: A Pathophysiologic Approach, 8th ed. New York: McGraw-Hill, 2012. Available at www.accesspharmacy.com/updatesContent.aspx?aid=4000198. Accessed October 19, 2012.
• Dennis A, Blanchard K, Córdova D, Wahlin B, Clark J, Edlund K, McIntosh J, Tsikitas L. What happens to women who fall through the cracks of health care reform? Lessons from Massachusetts. J Health Polit Policy Law. 2012 Dec 21.
• Rafie S, McIntosh J, Gardner DK, Gawronski K, Karaoui LR, Koepf ER, Lehman KJ, McBane S, Patel-Shori NM. Over-the-counter access to emergency contraception without age restriction: an opinion of the Women’s Health Practice and Research Network of the American College of Clinical Pharmacy. Pharmacotherapy 2013;33(5). [Epub ahead of print] 

Other Notable Achievements

Diane Goodwin and Sally Rafie are now Board Certified Pharmacotherapy Specialists.

Karen Gunning is 2013 Chair of BPS Pharmacotherapy Specialty Council.

Christina Madison is 2013 president* of Nevada Public Health Association (term: October 2012 – October 2013).

*One of two pharmacists in the country to hold this position in a public health association.

Katie McLendon received the Mississippi Board of Trustees of State Institutions of Higher Learning award as the University of Mississippi Medical Center’s 2013 Diversity Educator of the Year.